Processing 00000000.tx.1: Do antiangiogenic protein fragments have amyloid properties? 

Phrase: "Do"

Phrase: "antiangiogenic protein fragments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   884   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "have"

Phrase: "amyloid properties?"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]
Processing 00000000.tx.2: Martijn F. 

Phrase: "Martijn F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.3: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.4: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.5: Gebbink, Emile E. 

Phrase: "Gebbink,"

Phrase: "Emile E."
Processing 00000000.tx.6: Voest, and Arie Reijerkerk From the Laboratory of Thrombosis and Hemostasis, Department of Hematology and Department of Medical Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands. 

Phrase: "Voest,"

Phrase: "and"

Phrase: "Arie Reijerkerk From the Laboratory of Thrombosis"

Phrase: "and"

Phrase: "Hemostasis,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0019116:Haemostasis [Organ or Tissue Function]
  1000   C0740166:Haemostasis [Therapeutic or Preventive Procedure]
   928 E C0019120:Haemostatic [Pharmacologic Substance]
   900 E C0180950:Haemostat [Medical Device]

Phrase: "Department of Hematology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0587491:Haematology department [Health Care Related Organization]
   790   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Department of Medical Oncology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0587450:Medical department [Health Care Related Organization]
   770   C1704729:Department [Organization]

Phrase: "University Medical Centre Utrecht,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]

Phrase: "Utrecht,"

Phrase: "The Netherlands."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027778:The Netherlands [Geographic Area]
           Netherlands
Processing 00000000.tx.7: Abstract Tumor growth requires proteolytic activity. 

Phrase: "Abstract Tumor growth"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0598934:tumor growth [Neoplastic Process]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C0220844:growth [Physiologic Function]
   827   C1578706:Tumor [Intellectual Product]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]
   827   C3273930:Tumor [Finding]

Phrase: "requires"

Phrase: "proteolytic activity."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C0597304:Proteolytic [Molecular Function]
   861   C1561536:*Activity [Idea or Concept]
   861   C1947941:proteolytic [Enzyme]
Processing 00000000.tx.8: As a consequence, protein breakdown products are present in the circulation of patients with cancer. 

Phrase: "As a consequence,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0686907:Consequence [Functional Concept]

Phrase: "protein breakdown products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]
   734   C1623036:protein breakdown [Molecular Function]

Phrase: "are"

Phrase: "present in the circulation of patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]

Phrase: "with cancer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006826:Cancer [Neoplastic Process]
  1000   C0998265:Cancer [Eukaryote]
  1000   C1306459:Cancer [Finding]
Processing 00000000.tx.9: Within the past decade a large number of proteolytic fragments have been identified that inhibit angiogenesis and tumor growth. 

Phrase: "Within the past decade"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2981279:Decade [Quantitative Concept]

Phrase: "a large number of proteolytic fragments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "that"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "angiogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0302600:Angiogenesis [Organ or Tissue Function]
  1000   C1519670:angiogenesis [Neoplastic Process]

Phrase: "and"

Phrase: "tumor growth."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0598934:tumor growth [Neoplastic Process]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0027651:Tumor [Neoplastic Process]
   861   C0220844:growth [Physiologic Function]
   861   C1578706:Tumor [Intellectual Product]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   861   C3273930:Tumor [Finding]
Processing 00000000.tx.10: The mechanism of action of these inhibitors is still poorly understood. 

Phrase: "The mechanism of action of these inhibitors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   814   C0031327:mechanism of action [Physiologic Function]
   814   C1524059:mechanism of action [Functional Concept]
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "still poorly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205169:Poorly [Qualitative Concept]

Phrase: "understood."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]
Processing 00000000.tx.11: We recently found that the effects of the angiogenesis inhibitor endostatin on endothelial cells is critically dependent on the presence of cross- structure, a structure also present in amyloidogenic polypeptides in plaques of patients with amyloidosis, such as Alzheimer disease. 

Phrase: "We recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the effects of the angiogenesis inhibitor endostatin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   774   C3179307:Angiogenesis Effects [Physiologic Function]
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on endothelial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "critically dependent on the presence of cross- structure,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0851827:Dependent [Qualitative Concept]
   744   C1701901:Dependent [Qualitative Concept]
   744   C3244310:dependent [Functional Concept]

Phrase: "a structure also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "present in amyloidogenic polypeptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
   770   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]

Phrase: "in plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with amyloidosis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002726:Amyloidosis [Disease or Syndrome]

Phrase: "such as Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.12: We also showed that cross- structure containing endostatin is a ligand for tissue-type plasminogen activator (tPA). 

Phrase: "We also"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that cross- structure containing endostatin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0534628:Endostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C1332771:endostatin [Gene or Genome]
   812   C1705207:Endostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "is"

Phrase: "a ligand for tissue-type plasminogen activator (tPA)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0023688:Ligand [Chemical]
Processing 00000000.tx.13: We noted that many angiogenesis inhibitors stimulate tPA-mediated plasminogen activation. 

Phrase: "We"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "many angiogenesis inhibitors"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0596087:Angiogenesis Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C0302600:Angiogenesis [Organ or Tissue Function]
   861   C1519670:angiogenesis [Neoplastic Process]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "stimulate"

Phrase: "tPA-mediated plasminogen activation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   876   C1622667:plasminogen activation [Molecular Function]
   799   C1879547:Activation [Activity]
Processing 00000000.tx.14: Because the presence of cross- structure is the common denominator in tPA-binding ligands, we hypothesize that these endogenous antiangiogenic proteolytic fragments share features with amyloidogenic polypeptides. 

Phrase: "Because"

Phrase: "the presence of cross- structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "the common denominator in tPA-binding ligands,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2825218:Denominator [Quantitative Concept]

Phrase: "we"

Phrase: "hypothesize"

Phrase: "that"

Phrase: "these endogenous antiangiogenic proteolytic fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   779 E C1708096:Fragment [Qualitative Concept]

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "features with amyloidogenic polypeptides."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C1521970:Feature [Qualitative Concept]
   737   C1706388:Feature [Conceptual Entity]
   737   C2346469:Feature [Qualitative Concept]
   737   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.15: We postulate that the cross- structural fold is present in these antiangiogenic polypeptide fragments and that this structure mediates the inhibitory effects. 

Phrase: "We"

Phrase: "postulate"

Phrase: "that"

Phrase: "the cross- structural fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "is"

Phrase: "present in these antiangiogenic polypeptide fragments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "that"

Phrase: "this structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the inhibitory effects."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.16: The hypothesis provides new insights in the potential mechanisms of these angiogenesis inhibitors and offers opportunities to improve their use. 

Phrase: "The hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "new insights in the potential mechanisms of these angiogenesis inhibitors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0233820:insights [Mental Process]

Phrase: "and"

Phrase: "offers"

Phrase: "opportunities to"

Phrase: "improve"

Phrase: "their use."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]
Processing 00000000.tx.17: (Blood. 

Phrase: "(Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.18: 2004;104:1601-1605) Introduction Angiogenesis, the formation of new blood vessels from preexisting vasculature, occurs in physiologic and pathologic processes, including embryonic development, the menstrual cycle, wound healing, inflammation, and tumor growth (for a review, see Carmeliet and Jain1). 

Phrase: "2004"

Phrase: ";104"

Phrase: ":"

Phrase: "1601-1605"

Phrase: ")"

Phrase: "Introduction Angiogenesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0302600:Angiogenesis [Organ or Tissue Function]
   861   C1519670:angiogenesis [Neoplastic Process]

Phrase: "the formation of new blood vessels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "from preexisting vasculature,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005839:vasculature [Body Part, Organ, or Organ Component]

Phrase: "occurs in physiologic"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205463:Physiologic [Functional Concept]
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]
   718 E C0031842:Physiology [Biomedical Occupation or Discipline]
   718 E C0031843:physiology [Physiologic Function]

Phrase: "and"

Phrase: "pathologic processes,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0030660:Pathologic Processes [Pathologic Function]
   964 E C0677042:Pathology processes [Pathologic Function]
       E   pathology
   861   C1521733:Pathologic [Functional Concept]
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]
   789 E C0030664:Pathologies [Biomedical Occupation or Discipline]
   789 E C0205469:pathology [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "embryonic development,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0013936:Embryonic Development [Organ or Tissue Function]
  1000   C0243100:embryonic development [Functional Concept]
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "the menstrual cycle,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025329:Menstrual cycle [Organism Function]
   861   C0025344:Menstrual [Organism Function]
   861   C1511572:Cycle [Temporal Concept]

Phrase: "wound healing,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0043240:Wound Healing [Organism Function]
           Healing
   861   C0043250:Wound [Injury or Poisoning]
   861   C0205249:Healing [Functional Concept]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]

Phrase: "inflammation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021368:Inflammation [Pathologic Function]

Phrase: "and"

Phrase: "tumor growth"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0598934:tumor growth [Neoplastic Process]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0027651:Tumor [Neoplastic Process]
   861   C0220844:growth [Physiologic Function]
   861   C1578706:Tumor [Intellectual Product]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   861   C3273930:Tumor [Finding]

Phrase: "("

Phrase: "for a review,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Carmeliet"

Phrase: "and"

Phrase: "Jain1"

Phrase: ")."
Processing 00000000.tx.19: In 1971, Folkman2 postulated that tumor growth is dependent on angiogenesis. 

Phrase: "In 1971,"

Phrase: "Folkman2"

Phrase: "postulated"

Phrase: "that tumor growth"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0598934:tumor growth [Neoplastic Process]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0027651:Tumor [Neoplastic Process]
   861   C0220844:growth [Physiologic Function]
   861   C1578706:Tumor [Intellectual Product]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   861   C3273930:Tumor [Finding]

Phrase: "is"

Phrase: "dependent on angiogenesis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0851827:Dependent [Qualitative Concept]
   790   C1701901:Dependent [Qualitative Concept]
   790   C3244310:dependent [Functional Concept]
Processing 00000000.tx.20: Accumulating evidence indicates that drugs that target the growing vasculature are promising new therapeutics for the treatment of cancer. 

Phrase: "Accumulating evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "indicates"

Phrase: "that drugs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0013227:Drugs [Pharmacologic Substance]
   966 E C1254351:Drug [Pharmacologic Substance]
   928 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   928 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   900 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "that"

Phrase: "target"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "the growing vasculature"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005839:vasculature [Body Part, Organ, or Organ Component]

Phrase: "are"

Phrase: "promising"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1555307:promise [Idea or Concept]

Phrase: "new therapeutics for the treatment of cancer."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0039796:Therapeutics [Therapeutic or Preventive Procedure]
   748   C0723712:therapeutics [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.21: Based on the concept that a primary tumor produces inhibitors of angiogenesis that can inhibit the outgrowth of metastases, the first endogenous angiogenesis inhibitor, termed angiostatin, was purified in the laboratory of Folkman in 1994.3 The identification of angiostatin prompted the search for other angiogenesis inhibitors, resulting in the isolation of endostatin,4 prothrombin fragment 1 and 2,5 cleaved antithrombin III,6 fibrin(ogen) fragments (Brown et al7 and A.R., unpublished observations, September 1999) and many other inhibitory polypeptide fragments. 

Phrase: "Based on the concept"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0178566:concept [Idea or Concept]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "that"

Phrase: "a primary tumor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0677930:Primary Tumor [Neoplastic Process]
   861   C0027651:Tumor [Neoplastic Process]
   861   C0205225:Primary [Qualitative Concept]
   861   C0439631:Primary [Therapeutic or Preventive Procedure]
   861   C1578706:Tumor [Intellectual Product]
   861   C3273930:Tumor [Finding]

Phrase: "produces"

Phrase: "inhibitors of angiogenesis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   858   C0596087:Angiogenesis Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   790   C0243077:inhibitors [Chemical Viewed Functionally]
   756 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "that"

Phrase: "can"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the outgrowth of metastases,"

Phrase: "the first endogenous angiogenesis inhibitor,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0596087:Angiogenesis inhibitor [Biologically Active Substance,Pharmacologic Substance]
   812   C0302600:Angiogenesis [Organ or Tissue Function]
   812   C1519670:angiogenesis [Neoplastic Process]
   812   C1999216:Inhibitor [Qualitative Concept]

Phrase: "termed angiostatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0290149:Angiostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "was"

Phrase: "purified in the laboratory of Folkman"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0022877:Laboratory [Manufactured Object,Organization]
   753   C1998793:Purified [Functional Concept]
   753   C3244292:laboratory [Functional Concept]

Phrase: "in 1994.3"

Phrase: "The identification of angiostatin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]

Phrase: "prompted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871157:prompted [Functional Concept]
   966 E C1602245:Prompt [Pharmacologic Substance]

Phrase: "the search for other angiogenesis inhibitors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1552603:search [Intellectual Product]
   753   C1706202:Search [Activity]

Phrase: "resulting in the isolation of endostatin,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   790   C0332294:Resulting in [Functional Concept]
   753   C0204727:Isolation [Therapeutic or Preventive Procedure]
   753   C0205409:Isolation [Functional Concept]
   753   C0220862:isolation [Laboratory Procedure]
   753   C0534628:Endostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C0678226:resulting [Functional Concept]
   753   C1332771:endostatin [Gene or Genome]
   753   C1705207:Endostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   719 E C1274040:Result [Functional Concept]
   719 E C1546471:Result [Idea or Concept]
   719 E C2825142:Result [Finding]

Phrase: "4 prothrombin fragment 1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0072435:prothrombin fragment 1 [Amino Acid, Peptide, or Protein]
   812   C0033706:Prothrombin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]
   812   C2828369:Prothrombin [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "5 cleaved antithrombin III,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0003438:Antithrombin III [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Antithrombin
   861   C0724532:ANTITHROMBIN III [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0003440:Antithrombin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0439070:III [Intellectual Product]
   812   C1705160:III [Qualitative Concept]

Phrase: "6 fibrin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   789 E C0443215:Fibrinous [Qualitative Concept]

Phrase: "(ogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0722236:Ogen [Hormone,Pharmacologic Substance,Steroid]

Phrase: ")"

Phrase: "fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]

Phrase: "(Brown et al7"

Phrase: "and"

Phrase: "A.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "unpublished observations,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "September 1999"

Phrase: ")"

Phrase: "and"

Phrase: "many other inhibitory polypeptide fragments."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.22: Commonly, such antiangiogenic polypeptides are proteolytically cleaved or denatured derivatives of endogenous proteins. 

Phrase: "Commonly,"

Phrase: "such antiangiogenic polypeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]

Phrase: "are"

Phrase: "proteolytically"

Phrase: "cleaved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]

Phrase: "or"

Phrase: "denatured derivatives of endogenous proteins."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0243072:derivatives [Chemical Viewed Structurally]
   726 E C1527240:Derivative [Functional Concept]
Processing 00000000.tx.23: Endostatin, angiostatin, and a thrombospondin peptide are currently being tested in clinical trials.8-10 Background In 1997, Folkman and colleagues reported that treatment of experimental tumors with endostatin induced complete regression.11 These promising results from animal studies fueled the great expectations that accompanied the proposed use of antiangiogenic therapy with endogenous inhibitors of angiogenesis. 

Phrase: "Endostatin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0534628:Endostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1332771:endostatin [Gene or Genome]
  1000   C1705207:Endostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "angiostatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0290149:Angiostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "a thrombospondin peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "are"

Phrase: "currently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521116:Currently [Temporal Concept]

Phrase: "being"

Phrase: "tested in clinical trials.8-10 Background"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   778   C0008976:Clinical Trials [Research Activity]
           Trial
   778   C1096775:clinical trials [Intellectual Product]
   748   C0205210:Clinical [Qualitative Concept]
   748   C0392366:tested [Intellectual Product]
   748   C1706907:Background [Conceptual Entity]
   714 E C0022885:Test [Laboratory Procedure]
   714 E C0039593:Test [Functional Concept]

Phrase: "In 1997,"

Phrase: "Folkman"

Phrase: "and"

Phrase: "colleagues"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that treatment of experimental tumors"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "with endostatin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0534628:Endostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1332771:endostatin [Gene or Genome]
  1000   C1705207:Endostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "complete regression.11"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0205197:Complete [Qualitative Concept]
   827   C0684320:Regression [Pathologic Function]
   827   C0684321:Regression [Mental Process]
   827   C0725685:COMPLEAT [Food]
   755 E C0439812:Completeness [Qualitative Concept]

Phrase: "These promising results from animal studies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0683954:results studies [Finding]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "fueled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0556991:fueled [Manufactured Object]

Phrase: "the great expectations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679138:Expectations [Idea or Concept]

Phrase: "that"

Phrase: "accompanied"

Phrase: "the proposed use of antiangiogenic therapy"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1524063:Use of [Functional Concept]
   753   C0042153:use [Functional Concept]
   753   C0457083:Use [Functional Concept]
   753   C1947944:Use [Intellectual Product]

Phrase: "with endogenous inhibitors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205227:Endogenous [Functional Concept]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "of angiogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0302600:Angiogenesis [Organ or Tissue Function]
  1000   C1519670:angiogenesis [Neoplastic Process]
Processing 00000000.tx.24: However, the initial results could not be reproduced by others and lessened the initial enthusiasm.12 Controversies regarding the antitumor effects of endostatin arose and initiated a heated discussion about its efficacy.12 The variability in endostatin bioactivity is still unexplained. 

Phrase: "However,"

Phrase: "the initial results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "reproduced by others"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1955473:Others [Finding]

Phrase: "and"

Phrase: "lessened"

Phrase: "the initial enthusiasm.12 Controversies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0680243:controversies [Social Behavior]

Phrase: "regarding"

Phrase: "the antitumor effects of endostatin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C1280500:effects [Qualitative Concept]
   760   C2986475:Antitumor [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "arose"

Phrase: "and"

Phrase: "initiated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1548602:Initiate [Idea or Concept]
   966   C1704686:Initiate [Functional Concept]

Phrase: "a heated discussion about its efficacy.12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0557061:Discussion [Therapeutic or Preventive Procedure]
   748   C2584313:Discussion [Social Behavior]

Phrase: "The variability in endostatin bioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2827666:Variability [Conceptual Entity]

Phrase: "is"

Phrase: "still unexplained."
Processing 00000000.tx.25: Originally, endostatin was purified from tissue culture supernatant. 

Phrase: "Originally,"

Phrase: "endostatin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0534628:Endostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1332771:endostatin [Gene or Genome]
  1000   C1705207:Endostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "was"

Phrase: "purified from tissue culture supernatant."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0040284:Tissue culture [Laboratory Procedure]
   760   C0010453:Culture [Idea or Concept]
   760   C0040300:Tissue [Tissue]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C1547928:Tissue [Intellectual Product]
   760   C1550101:Supernatant [Body Substance]
   760   C1998793:Purified [Functional Concept]
   760   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.26: In the in vivo experiments that showed dramatic tumor regression a recombinant denatured and insoluble form of endostatin produced in Escherichia coli was used.11 In a number of subsequent studies endostatin has been used from a number of different sources. 

Phrase: "In the in vivo experiments"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "that"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "dramatic tumor regression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1718423:Tumor regression [Organism Attribute]
   827   C0684320:Regression [Pathologic Function]
   827   C0684321:Regression [Mental Process]

Phrase: "a recombinant denatured"

Phrase: "and"

Phrase: "insoluble form of endostatin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1522492:Form [Functional Concept]

Phrase: "produced in Escherichia coli"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0014834:Escherichia coli [Bacterium]
   770   C0014833:Escherichia [Bacterium]

Phrase: "was"

Phrase: "used.11 In a number of subsequent studies endostatin"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   745   C0869040:Use studies [Research Activity]
   745   C1524063:Use of [Functional Concept]
   742   C0237753:*Number [Quantitative Concept]
   742   C0332282:Subsequent [Temporal Concept]
   742   C0449788:Number [Quantitative Concept]
   742   C0534628:Endostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   742   C0947630:studies [Laboratory Procedure]
   742   C1273517:used [Finding]
   742   C1332771:endostatin [Gene or Genome]
   742   C1705207:Endostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   708 E C0042153:use [Functional Concept]
   708 E C0457083:Use [Functional Concept]
   708 E C0557651:Study [Manufactured Object]
   708 E C1947944:Use [Intellectual Product]
   708 E C2603343:Study [Research Activity]

Phrase: "has"

Phrase: "been"

Phrase: "used from a number of different sources."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   757   C1524063:Use of [Functional Concept]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449416:sources [Finding]
   748   C0449788:Number [Quantitative Concept]
   748   C1273517:used [Finding]
   748   C1705242:Different [Qualitative Concept]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1705919:Source [Idea or Concept]
   714 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.27: These different endostatin preparations caused less dramatic, minor, or even no effects.13-16 For studies in patients, a soluble globular form is used, produced in Pichia pastoris.8 However, this globular form has no or very little effect on endothelial cells.17 We found that only denatured endostatin is toxic to cells.18 We wondered whether our findings might explain the observed variability in endostatin bioactivity and to what extent our observations could be extrapolated to other angiogenesis inhibitors. 

Phrase: "These different endostatin preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0455052:Preparation [Health Care Activity]
   793   C1521827:Preparation [Functional Concept]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "less dramatic, minor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026193:Minor [Population Group]
   827   C0205165:Minor [Qualitative Concept]

Phrase: "or"

Phrase: "even"

Phrase: "no effects.13-16 For studies"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   773   C1301751:No effect [Qualitative Concept]
   753   C0947630:studies [Laboratory Procedure]
   753   C1280500:effects [Qualitative Concept]
   753   C1298908:no [Idea or Concept]
   753   C1549444:No [Idea or Concept]
   719 E C0557651:Study [Manufactured Object]
   719 E C2348382:Effect [Qualitative Concept]
   719 E C2603343:Study [Research Activity]

Phrase: "in patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "a soluble globular form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0348078:Form [Qualitative Concept]
   827   C0376315:Form [Manufactured Object]
   827   C1522492:Form [Functional Concept]

Phrase: "is"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "produced in Pichia pastoris.8 However,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0031874:Pichia [Fungus]

Phrase: "this globular form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "has"

Phrase: "no"

Phrase: "or"

Phrase: "very little effect on endothelial cells.17"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that only denatured endostatin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0534628:Endostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C1332771:endostatin [Gene or Genome]
   827   C1705207:Endostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "is"

Phrase: "toxic to cells.18"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0600688:toxic [Injury or Poisoning]
   770   C1407029:Toxic [Qualitative Concept]

Phrase: "We"

Phrase: "wondered"

Phrase: "whether"

Phrase: "our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "might"

Phrase: "explain"

Phrase: "the observed variability in endostatin bioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2827666:Variability [Conceptual Entity]

Phrase: "and to what extent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439792:Extent [Spatial Concept]
   770   C1515981:And [Idea or Concept]

Phrase: "our observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "could"

Phrase: "be"

Phrase: "extrapolated to other angiogenesis inhibitors."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0596087:Angiogenesis Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   760   C0243077:inhibitors [Chemical Viewed Functionally]
   760   C0302600:Angiogenesis [Organ or Tissue Function]
   760   C1519670:angiogenesis [Neoplastic Process]
   726 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.28: Inherent toxicity of unfolded proteins Similar to certain antiangiogenic polypeptides, toxic polypeptides involved in conformational diseases such as Alzheimer disease (AD), light-chain amyloidosis, pancreatic islet amyloidosis, and spongiform encephalopathies are proteolytic fragments or conformationally changed forms of generally harmless proteins. 

Phrase: "Inherent toxicity of unfolded proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0815048:toxic proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0040539:toxicity [Qualitative Concept]
   760   C0600688:Toxicity [Injury or Poisoning]

Phrase: "Similar to certain antiangiogenic polypeptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "toxic polypeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]

Phrase: "involved in conformational diseases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0012634:Diseases [Disease or Syndrome]
   770   C1314939:Involved [Functional Concept]

Phrase: "such as Alzheimer disease (AD),"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "light-chain amyloidosis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002726:Amyloidosis [Disease or Syndrome]

Phrase: "pancreatic islet amyloidosis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0002726:Amyloidosis [Disease or Syndrome]
   734   C0022131:Pancreatic islet [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "spongiform encephalopathies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C0162534:Spongiform encephalopathy [Disease or Syndrome]
   861   C0085584:Encephalopathies [Disease or Syndrome]
   827 E C1963101:Encephalopathy [Finding]

Phrase: "are"

Phrase: "proteolytic fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "or"

Phrase: "conformationally changed forms of generally harmless proteins."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0348078:forms [Qualitative Concept]
   748   C0376315:Forms [Manufactured Object]
   714 E C1522492:Form [Functional Concept]
Processing 00000000.tx.29: Properly folded proteins form a stable 3-dimensional structure. 

Phrase: "Properly folded proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a stable 3-dimensional structure."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0678594:Structure [Spatial Concept]
Processing 00000000.tx.30: However, protein fragments (such as endostatin) are often prone to (partial) denaturation and undergo sequential aggregation steps leading to the formation of highly ordered aggregates. 

Phrase: "However,"

Phrase: "protein fragments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   983   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "("

Phrase: "such as endostatin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0534628:Endostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1332771:endostatin [Gene or Genome]
  1000   C1705207:Endostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ")"

Phrase: "are"

Phrase: "often prone to (partial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0728938:Partial [Quantitative Concept]
   812   C1550516:partial [Idea or Concept]

Phrase: ")"

Phrase: "denaturation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0301642:Denaturation [Molecular Function]

Phrase: "and"

Phrase: "undergo"

Phrase: "sequential aggregation steps"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C1261552:steps [Conceptual Entity]
   793 E C1704379:Step [Functional Concept]
   793 E C1705117:Step [Quantitative Concept]
   793 E C2825408:Step [Manufactured Object]

Phrase: "leading to the formation of highly ordered aggregates."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   744   C0205250:Highly [Qualitative Concept]
   744   C0205418:aggregates [Qualitative Concept]
   744   C0220781:formation [Biologic Function]
   744   C0332152:Leading [Temporal Concept]
   744   C0439634:formation [Spatial Concept]
   744   C1522492:Formation [Functional Concept]
   744   C1522538:Leading [Functional Concept]
   744   C1705176:Ordered [Qualitative Concept]
   744   C1705178:Ordered [Activity]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.31: Initially, (partly) unfolded proteins or protein fragments associate with each other and form small soluble aggregates, preceding the formation of protofibrils. 

Phrase: "Initially,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "(partly"

Phrase: ")"

Phrase: "unfolded proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "protein fragments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   983   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "associate with each other"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0750490:Associate [Idea or Concept]
   770   C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "small soluble aggregates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205418:aggregates [Qualitative Concept]

Phrase: "preceding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332152:Preceding [Temporal Concept]

Phrase: "the formation of protofibrils."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]
Processing 00000000.tx.32: Ultimately, mature fibrils accumulate and are deposited as plaques. 

Phrase: "Ultimately,"

Phrase: "mature fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0225328:fibrils [Cell Component]
   827 E C1948066:Fibril [Physical Object]

Phrase: "accumulate"

Phrase: "and"

Phrase: "are"

Phrase: "deposited as plaques."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0333463:plaques [Acquired Abnormality]
   790   C0333562:deposited [Functional Concept]
   756 E C0011389:Plaque [Disease or Syndrome]
   756 E C0332461:Plaque [Finding]
Processing 00000000.tx.33: Fibrillar aggregates are classified as amyloid fibrils based on the presence of cross- structure. 

Phrase: "Fibrillar aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "are"

Phrase: "classified as amyloid fibrils"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0008902:Classified [Classification]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0225328:fibrils [Cell Component]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737 E C1948066:Fibril [Physical Object]

Phrase: "based on the presence of cross- structure."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0678594:Structure [Spatial Concept]
   748   C1527178:Based [Functional Concept]
   748   C1705938:Based [Idea or Concept]
   748   C2828360:Cross [Conceptual Entity]
   714 E C0002055:base [Inorganic Chemical]
   714 E C0178499:Base [Chemical Viewed Functionally]
   714 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.34: Cross- structures in amyloid fibrils are stacked sheets composed of flat and nontwisted strands. 

Phrase: "Cross- structures in amyloid fibrils"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0678594:structures [Spatial Concept]

Phrase: "are"

Phrase: "stacked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3272897:Stack [Spatial Concept]

Phrase: "sheets"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0439643:Sheets [Spatial Concept]
   966 E C2349187:Sheet [Quantitative Concept]

Phrase: "composed of flat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205324:Flat [Spatial Concept]
   790   C0457933:Flat [Manufactured Object]

Phrase: "and"

Phrase: "nontwisted strands."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704972:Strand [Spatial Concept]
   827   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.35: This will result in a unique and flat 2-dimensional -sheet surface, not seen in globular proteins (Figure 1). 

Phrase: "This"

Phrase: "will"

Phrase: "result in a unique"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C1710548:Unique [Qualitative Concept]
   770   C2825142:Result [Finding]

Phrase: "and"

Phrase: "flat 2-dimensional -sheet surface,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0205148:Surface [Spatial Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "seen in globular proteins"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   799   C0178663:globular protein [Amino Acid, Peptide, or Protein]
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0205397:Seen [Qualitative Concept]
   770   C0332501:Globular [Spatial Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "(Figure 1"

Phrase: ")."
Processing 00000000.tx.36: The list of amyloidogenic peptides arising from proteolytic processing of harmless proteins is long and still increasing (for a review, see Selkoe19). 

Phrase: "The list of amyloidogenic peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0745732:List [Conceptual Entity]
   760   C3272378:LIST [Intellectual Product]

Phrase: "arising from proteolytic processing of harmless proteins"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1514570:Proteolytic Processing [Molecular Function]
   757   C0033666:protein processing [Molecular Function]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0332284:arising [Qualitative Concept]
   748   C0597304:Proteolytic [Molecular Function]
   748   C1709694:Processing [Activity]
   748   C1947941:proteolytic [Enzyme]

Phrase: "is"

Phrase: "long"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205166:Long [Qualitative Concept]
  1000   C1706317:Long [Qualitative Concept]

Phrase: "and"

Phrase: "still"

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "("

Phrase: "for a review,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Selkoe19"

Phrase: ")."
Processing 00000000.tx.37: In addition to disease-associated amyloid formation, intriguing physiologic roles for amyloid fibril formation have been elucidated.20,21 These recent reports highlight such a behavior of specific proteins or protein fragments in microorganisms as well as in eukaryotes. 

Phrase: "In addition to disease-associated amyloid formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0220781:formation [Biologic Function]
   812   C0439634:formation [Spatial Concept]
   812   C1522492:Formation [Functional Concept]

Phrase: "intriguing"

Phrase: "physiologic roles for amyloid fibril formation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0035820:Roles [Social Behavior]
   719 E C1705810:Role [Conceptual Entity]

Phrase: "have"

Phrase: "been"

Phrase: "elucidated.20,"

Phrase: "21"

Phrase: "These recent reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "highlight"

Phrase: "such a behavior of specific proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0004927:Behavior [Individual Behavior]
   753   C2707008:Behavior [Clinical Attribute]

Phrase: "or"

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "fragments in microorganisms"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0332255:fragment [Functional Concept]
   790   C0445623:Microorganisms [Organism]
   790   C0486805:Fragments [Body Substance]
   790   C1708096:Fragment [Qualitative Concept]
   756 E C2827713:Microorganism [Intellectual Product]

Phrase: "as well as in eukaryotes."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0205170:Well [Qualitative Concept]
   760   C0684063:Eukaryotes [Eukaryote]
   760   C3146287:Well [Manufactured Object]
   726 E C0015161:eukaryote [Cell]
Processing 00000000.tx.38: It is expected that numerous other proteins will be found to form amyloid as a natural product. 

Phrase: "It"

Phrase: "is"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "that numerous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439064:Numerous [Quantitative Concept]

Phrase: "other proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "will"

Phrase: "be"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "amyloid as a natural product."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0002723:Amyloid A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.39: View larger version (15K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.40: Illustration of amyloid formation and cross- structure. 

Phrase: "Illustration of amyloid formation"

Phrase: "and"

Phrase: "cross- structure."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]
Processing 00000000.tx.41: (A) Initiation of amyloid fibrillization by a partially structured conformer. 

Phrase: "(A) Initiation of amyloid fibrillization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0589507:Initiation [Mental Process]
   760   C1158830:Initiation [Genetic Function]
   760   C1704686:Initiation [Functional Concept]

Phrase: "by a partially structured conformer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0180093:Conformer [Medical Device]
Processing 00000000.tx.42: An unstable amyloidogenic intermediate is formed via partial unfolding of a compact globular protein (i) or via the gain of structure by a natively unfolded polypeptide (ii). 

Phrase: "An unstable amyloidogenic intermediate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205103:Intermediate [Spatial Concept]
   827   C1550465:intermediate [Idea or Concept]
   827   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "is"

Phrase: "formed via partial unfolding of a compact globular protein"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   764   C0178663:globular protein [Amino Acid, Peptide, or Protein]
   762   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   762   C1655065:Protein Unfolding [Cell Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205431:Formed [Functional Concept]
   742   C0332501:Globular [Spatial Concept]
   742   C0728938:Partial [Quantitative Concept]
   742   C1333134:Compact [Finding]
   742   C1550516:partial [Idea or Concept]
   708 E C0348078:Form [Qualitative Concept]
   708 E C0376315:Form [Manufactured Object]
   708 E C1522492:Form [Functional Concept]

Phrase: "(i)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "or via the gain of structure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0678594:Structure [Spatial Concept]
   753   C1517378:Gain [Quantitative Concept]

Phrase: "by a natively unfolded polypeptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "(ii"

Phrase: ")."
Processing 00000000.tx.43: The partially ordered intermediate, which contains some structure (depicted as a green block arrow), is stabilized by ordered self-assembly (iii) to form a nucleus enriched with sheet. 

Phrase: "The partially"

Phrase: "ordered"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1705176:Ordered [Qualitative Concept]
  1000   C1705178:Ordered [Activity]
   966 E C1705175:Order [Intellectual Product]
   966 E C1705177:Order [Classification]
   966 E C1882348:Order [Qualitative Concept]

Phrase: "intermediate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205103:Intermediate [Spatial Concept]
  1000   C1550465:intermediate [Idea or Concept]
  1000   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "which"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "some structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "("

Phrase: "depicted as a green block arrow"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0028778:Block [Pathologic Function]
   753   C0332206:Block [Functional Concept]
   753   C0332583:Green [Qualitative Concept]
   753   C0336721:Arrow [Manufactured Object]
   753   C1533157:Block [Substance]
   753   C1706084:Block [Geographic Area]
   753   C2828370:Block [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "is"

Phrase: "stabilized by ordered self-assembly"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0036588:Self [Idea or Concept]
   760   C0184512:Stabilized [Qualitative Concept]
   760   C1551994:self [Intellectual Product]
   760   C1705176:Ordered [Qualitative Concept]
   760   C1705178:Ordered [Activity]
   760   C1706853:Assembly [Activity]
   760   C1879748:Assembly [Manufactured Object]
   760   C3244295:Self [Intellectual Product]

Phrase: "(iii"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "enriched with sheet."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0359583:enriched [Food]
   790   C2349187:Sheet [Quantitative Concept]
Processing 00000000.tx.44: Alternatively, self-association may lead to the formation of large amorphous aggregates (iv). 

Phrase: "Alternatively,"

Phrase: "self-association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "may"

Phrase: "lead to the formation of large amorphous aggregates"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0205418:aggregates [Qualitative Concept]
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C0549177:Large [Quantitative Concept]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1522492:Formation [Functional Concept]
   744   C1522538:Lead [Functional Concept]
   744   C1979848:Amorphous [Qualitative Concept]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(iv"

Phrase: ")."
Processing 00000000.tx.45: The amorphous aggregates may facilitate nucleation by providing a high local concentration of amyloidogenic intermediates (v). 

Phrase: "The amorphous aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "may"

Phrase: "facilitate"

Phrase: "nucleation by providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C1979936:Nucleated [Qualitative Concept]

Phrase: "a high local concentration of amyloidogenic intermediates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]

Phrase: "(v)."
Processing 00000000.tx.46: Growth of the nucleus by -sheet extension leads to the formation of higher order oligomers (vi) and fibrils (vii). 

Phrase: "Growth of the nucleus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0018270:'growth' NOS [Organism Function]
   770   C0220844:growth [Physiologic Function]
   770   C1621966:Growth [Organ or Tissue Function]
   770   C2911660:Growth [Activity]

Phrase: "by -sheet extension"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0231448:Extension [Functional Concept]
   861   C1880641:Extension [Conceptual Entity]

Phrase: "leads to the formation of higher order oligomers"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   750   C0861064:high lead [Finding]
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0181586:leads [Medical Device]
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1522492:Formation [Functional Concept]
   744   C1522538:Lead [Functional Concept]
   744   C1705175:Order [Intellectual Product]
   744   C1705176:Order [Qualitative Concept]
   744   C1705177:Order [Classification]
   744   C1705178:Order [Activity]
   744   C1882348:Order [Qualitative Concept]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]
   711   C0205250:High [Qualitative Concept]
   711   C1299351:High [Qualitative Concept]
   711   C2700149:HIGH [Intellectual Product]

Phrase: "(vi)"

Phrase: "and"

Phrase: "fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "(vii"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445385:VII [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.47: The fibril may consist of antiparallel, as well as parallel, sheet. 

Phrase: "The fibril"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0225328:Fibril [Cell Component]
  1000   C1948066:Fibril [Physical Object]

Phrase: "may"

Phrase: "consist of antiparallel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332529:CONSIST [Qualitative Concept]

Phrase: "as well as"

Phrase: "parallel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2348042:Parallel [Qualitative Concept]
  1000   C2826345:PARALLEL [Research Activity]

Phrase: "sheet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349187:Sheet [Quantitative Concept]
Processing 00000000.tx.48: For details, see Rochet and Lansbury.61 (B) Amyloid cross- structure. 

Phrase: "For details,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522508:Details [Qualitative Concept]
   966 E C1561567:detail [Functional Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Rochet"

Phrase: "and"

Phrase: "Lansbury.61"

Phrase: "(B) Amyloid cross- structure."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0678594:Structure [Spatial Concept]
Processing 00000000.tx.49: In amyloid fibrils, cross- structures are stacked sheets likely composed of flat and nontwisted strands. 

Phrase: "In amyloid fibrils,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0225328:fibrils [Cell Component]
   827 E C1948066:Fibril [Physical Object]

Phrase: "cross- structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:structures [Spatial Concept]

Phrase: "are"

Phrase: "stacked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3272897:Stack [Spatial Concept]

Phrase: "sheets likely"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439643:Sheets [Spatial Concept]
   827 E C2349187:Sheet [Quantitative Concept]

Phrase: "composed of flat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205324:Flat [Spatial Concept]
   790   C0457933:Flat [Manufactured Object]

Phrase: "and"

Phrase: "nontwisted strands."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704972:Strand [Spatial Concept]
   827   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.50: This will result in a unique and flat 2-dimensional -sheet surface, not seen in globular proteins. 

Phrase: "This"

Phrase: "will"

Phrase: "result in a unique"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C1710548:Unique [Qualitative Concept]
   770   C2825142:Result [Finding]

Phrase: "and"

Phrase: "flat 2-dimensional -sheet surface,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0205148:Surface [Spatial Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "seen in globular proteins."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   799   C0178663:globular protein [Amino Acid, Peptide, or Protein]
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0205397:Seen [Qualitative Concept]
   770   C0332501:Globular [Spatial Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]
Processing 00000000.tx.51: The inter- strand distance of 4.7  that is measured using x-ray fiber diffraction is an import characteristic not seen in globular proteins.  

Phrase: "The inter- strand distance of 4.7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0012751:Distance [Quantitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "x-ray fiber diffraction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   923   C0043301:X-Ray Diffraction [Laboratory Procedure]

Phrase: "is"

Phrase: "an import"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0699788:Import [Occupational Activity]

Phrase: "characteristic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521970:Characteristic [Qualitative Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "seen in globular proteins."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   799   C0178663:globular protein [Amino Acid, Peptide, or Protein]
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0205397:Seen [Qualitative Concept]
   770   C0332501:Globular [Spatial Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]
Processing 00000000.tx.52: The formation of amyloid aggregates and their relation to disease are studied intensively (for reviews, see Selkoe19 and Dobson22). 

Phrase: "The formation of amyloid aggregates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "their relation to disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0080103:Relation [Family Group]
   770   C0869014:relation [Social Behavior]

Phrase: "are"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "intensively"

Phrase: "("

Phrase: "for reviews,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0282443:reviews [Intellectual Product]
   966 E C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Selkoe19"

Phrase: "and"

Phrase: "Dobson22"

Phrase: ")."
Processing 00000000.tx.53: Just recently a common, although unknown, mechanism of cell toxicity has been implied for protein misfolding diseases. 

Phrase: "Just recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332185:Recently [Temporal Concept]

Phrase: "a common,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205214:Common [Quantitative Concept]
  1000   C1522138:Common [Functional Concept]
  1000   C3245511:common [Intellectual Product]

Phrase: "although"

Phrase: "unknown, mechanism of cell toxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "has"

Phrase: "been"

Phrase: "implied for protein misfolding diseases."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   862   C2718001:Protein Misfolding Diseases [Disease or Syndrome]
   760   C0012634:Diseases [Disease or Syndrome]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.54: Toxicity is an inherent property of aggregates of denatured proteins and is not related to the amino acid sequence composition of the protein.23 Although the nature of the toxicity remains unclear, recent studies suggest that the toxicity of amyloid proteins is enclosed in soluble oligomers, rather than in fibrils.24-26 This notion is supported by the finding that antibodies that detect early amyloidogenic aggregates can inhibit their toxicity.27 Many studies have indicated a close relationship between the presence of amyloid depositions and vascular damage. 

Phrase: "Toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0040539:toxicity [Qualitative Concept]
  1000   C0600688:Toxicity [Injury or Poisoning]
   928 E C1407029:Toxic [Qualitative Concept]
   907 E C0032346:Poison [Hazardous or Poisonous Substance]
   907 E C1548769:Poison [Intellectual Product]
   907 E C1550590:poison [Idea or Concept]

Phrase: "is"

Phrase: "an inherent property of aggregates of denatured proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0871161:Property [Qualitative Concept]
   744   C1882134:Property [Conceptual Entity]
   744   C2347695:Property [Entity]

Phrase: "and"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "related to the amino acid sequence composition of the protein.23"
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   808   C0920679:aminoacid sequence of protein [Amino Acid Sequence]
   775   C0002518:Amino Acid Sequence [Amino Acid Sequence]
           Protein Sequence
   772   C1874187:amino acid protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   756   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756   C2917660:Amino Acid [Pharmacologic Substance]
   738   C0001128:Acid [Chemical]
   738   C0004793:Sequence [Nucleotide Sequence]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0162326:Sequence [Nucleotide Sequence]
   738   C0162327:Sequence [Nucleotide Sequence]
   738   C0202406:Acid [Laboratory Procedure]
   738   C0439849:Related [Qualitative Concept]
   738   C0445223:Related [Finding]
   738   C0450348:23 [Quantitative Concept]
   738   C0486616:Composition [Clinical Attribute]
   738   C1519249:Sequence [Functional Concept]
   738   C1555710:composition [Idea or Concept]
   704 E C0163712:Relate [Organic Chemical]

Phrase: "Although"

Phrase: "the nature of the toxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0349590:Nature [Idea or Concept]
   760   C1262865:Nature [Functional Concept]

Phrase: "remains"

Phrase: "unclear, recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the toxicity of amyloid proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0815048:toxic proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0040539:toxicity [Qualitative Concept]
   760   C0600688:Toxicity [Injury or Poisoning]

Phrase: "is"

Phrase: "enclosed in soluble oligomers,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205380:Enclosed [Spatial Concept]
   770   C1749467:soluble [Cell Component]
   770   C1948047:Soluble [Qualitative Concept]

Phrase: "rather than in fibrils.24-26"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0225328:fibrils [Cell Component]
   719 E C1948066:Fibril [Physical Object]

Phrase: "This notion"

Phrase: "is"

Phrase: "supported by the finding"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0037088:Finding [Sign or Symptom]
   770   C0243095:Finding [Finding]
   770   C1521721:Supported [Conceptual Entity]
   770   C2825141:Finding [Finding]
   737 E C0183683:Support [Medical Device]

Phrase: "that antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "that"

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "early amyloidogenic aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205418:aggregates [Qualitative Concept]

Phrase: "can"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "their toxicity.27"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]

Phrase: "Many studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "a close relationship between the presence of amyloid depositions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C1821461:Close Relationship [Finding]
   742   C0439849:Relationship [Qualitative Concept]
   742   C1705630:Relationship [Idea or Concept]
   742   C1706279:Relationship [Idea or Concept]
   742   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "vascular damage."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010957:Damage [Injury or Poisoning]
   861   C1883709:Damage [Functional Concept]
Processing 00000000.tx.55: Transmissible spongiform disease is associated with the presence of the abnormal form of prion protein that aggregates into amyloid fibrils. 

Phrase: "Transmissible spongiform disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   913   C0009450:Transmissible disease, NOS [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "associated with the presence of the abnormal form of prion protein"
Meta Candidates (Total=22; Excluded=2; Pruned=0; Remaining=20)
   788   C0033672:Abnormal presence of protein [Finding]
           Protein, abnormal presence
   772   C0332198:Abnormal presence of [Functional Concept]
           abnormal presence
   772   C1545587:Prion protein.abnormal [Finding]
   756   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   756   C0332281:Associated with [Qualitative Concept]
           Associated
   756   C0439172:abnormal form [Quantitative Concept]
   756   C1418941:PRION PROTEIN [Gene or Genome]
   754   C0311448:Abnormal protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0205161:Abnormal [Qualitative Concept]
   738   C0348078:Form [Qualitative Concept]
   738   C0376315:Form [Manufactured Object]
   738   C0392148:Presence [Therapeutic or Preventive Procedure]
   738   C1522492:Form [Functional Concept]
   738   C2347472:% Abnormal [Quantitative Concept]
   738   C2699333:ABNORMAL [Intellectual Product]
   704 E C0750490:Associate [Idea or Concept]
   704 E C1706221:Associate [Professional or Occupational Group]

Phrase: "that aggregates into amyloid fibrils."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205418:aggregates [Qualitative Concept]
Processing 00000000.tx.56: Prion deposits are toxic to a wide variety of cells, including cerebral endothelial cells.28 Damage to endothelial cells is also seen in AD. 

Phrase: "Prion deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposits [Functional Concept]

Phrase: "are"

Phrase: "toxic to a wide variety of cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0600688:toxic [Injury or Poisoning]
   748   C1407029:Toxic [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "cerebral endothelial cells.28 Damage to endothelial cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0270611:cerebral damage [Injury or Poisoning]
   767   C0599732:cells damage [Cell or Molecular Dysfunction]
   744   C0010957:Damage [Injury or Poisoning]
   744   C1883709:Damage [Functional Concept]

Phrase: "is"

Phrase: "also"

Phrase: "seen in AD."
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0205397:Seen [Qualitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.57: Patients with AD exhibit significant cerebrovascular pathology in addition to neuronal degeneration.29,30 Furthermore, it is known that patients with AD suffer from stroke and that hemorrhages are present.31 In vitro experiments revealed that amyloid increases permeability of endothelial cell monolayers and induces apoptosis.32,33 Other studies have shown that smooth muscle cells and endothelial cells are damaged in cerebral blood vessels of those with AD.33-35 Finally, the diabetes-related amyloidogenic peptide amylin and the circulating amyloidogenic peptide 2-microglobulin damage blood vessels.36 We recently showed that insoluble endostatin forms amyloid fibrils, suggesting that endostatin may induce apoptosis as a consequence of its amyloid structure.18,37 In AD endostatin colocalized with amyloid -positive plaques that were surrounded by focal gliosis.38 These studies indicate that the cross- structure has direct effects on endothelial cells. 

Phrase: "Patients with AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030705:Patients [Patient or Disabled Group]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "significant cerebrovascular pathology in addition to neuronal degeneration.29,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0030664:Pathology [Biomedical Occupation or Discipline]
   742   C0205469:pathology [Functional Concept]
   742   C0677042:pathology [Pathologic Function]

Phrase: "30 Furthermore,"

Phrase: "it"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that patients with AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030705:Patients [Patient or Disabled Group]

Phrase: "suffer from stroke"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0038454:Stroke [Disease or Syndrome]
   790   C0683278:suffer [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "that hemorrhages"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019080:HEMORRHAGES [Pathologic Function]

Phrase: "are"

Phrase: "present.31 In vitro experiments"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   840   C0021135:In Vitro [Intellectual Product]
   840   C1533691:in vitro [Qualitative Concept]
           vitro
   840   C2827718:In Vitro [Functional Concept]
   804   C0681814:Experiments [Research Activity]
   771 E C1706386:Experiment [Conceptual Entity]
   721 E C1517586:Experimental [Qualitative Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "permeability of endothelial cell monolayers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0031164:Permeability [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis.32,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "33"

Phrase: "Other studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that smooth muscle cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
  1000   C1135918:Smooth Muscle Cells [Cell]
   901   C0596981:Muscle Cells [Cell]
   901   C1267092:Muscle, Smooth [Tissue]
   827   C0007634:Cells [Cell]
   827   C0026845:Muscle [Tissue]
   827   C0205357:Smooth [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "and"

Phrase: "endothelial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "damaged in cerebral blood vessels"
Meta Candidates (Total=16; Excluded=9; Pruned=0; Remaining=7)
   806   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   797   C0225992:Cerebral vessels [Body System]
   797   C1283832:Cerebral vessels [Body Part, Organ, or Organ Component]
   781   C0270611:cerebral damage [Injury or Poisoning]
   773 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   773 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   735 E C1558950:VASCULAR [Finding]
   735 E C1801960:Vascular [Qualitative Concept]
   726   C0010957:Damage [Injury or Poisoning]
   726   C1883709:Damage [Functional Concept]
   714 E C0005767:Blood [Tissue]
   714 E C0005768:blood [Body Substance]
   714 E C0229664:Blood [Body Substance]
   714 E C0392895:Bloods [Population Group]

Phrase: "of those with AD.33-35 Finally,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   827   C0002395:Alzheimer's Disease [Disease or Syndrome]
   827   C1521724:Alzheimer's Disease [Pathologic Function]
   799   C0012634:Disease [Disease or Syndrome]
   799   C0332287:With [Qualitative Concept]
   799   C1705690:With [Intellectual Product]
   743 E C1836721:MALS [Finding]
   743 E C3538764:MALS [Gene or Genome]
   743 E C3540595:MAL [Gene or Genome]

Phrase: "the diabetes-related amyloidogenic peptide amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   804   C1415831:AMYLIN [Gene or Genome]

Phrase: "and"

Phrase: "the circulating amyloidogenic peptide 2-microglobulin damage blood vessels.36"
Meta Candidates (Total=18; Excluded=10; Pruned=0; Remaining=8)
   837   C0440738:Circulating blood [Body Substance]
   807   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   791   C0010957:Damage [Injury or Poisoning]
   791   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   791   C0175630:Circulating [Functional Concept]
   791   C1883709:Damage [Functional Concept]
   791   C1979927:Microglobulin [Amino Acid, Peptide, or Protein]
   774 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   774 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   736 E C1558950:VASCULAR [Finding]
   736 E C1801960:Vascular [Qualitative Concept]
   720 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]
   715 E C0005767:Blood [Tissue]
   715 E C0005768:blood [Body Substance]
   715 E C0229664:Blood [Body Substance]
   715 E C0392895:Bloods [Population Group]

Phrase: "We recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that insoluble endostatin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0534628:Endostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C1332771:endostatin [Gene or Genome]
   861   C1705207:Endostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "amyloid fibrils,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0225328:fibrils [Cell Component]
   827 E C1948066:Fibril [Physical Object]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that endostatin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0534628:Endostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1332771:endostatin [Gene or Genome]
  1000   C1705207:Endostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "may"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis as a consequence of its amyloid structure.18,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0162638:Apoptosis [Cell Function]

Phrase: "37 In AD endostatin"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0534628:Endostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   760   C1332771:endostatin [Gene or Genome]
   760   C1705207:Endostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "colocalized with amyloid -positive plaques"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   797   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   797   C2936349:Plaques, Amyloid [Acquired Abnormality]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0439178:% Positive [Quantitative Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1446409:Positive [Qualitative Concept]
   760   C1514241:Positive [Finding]
   760   C2825490:Positive [Qualitative Concept]
   726 E C0011389:Plaque [Disease or Syndrome]
   726 E C0332461:Plaque [Finding]

Phrase: "that"

Phrase: "were"

Phrase: "surrounded by focal gliosis.38"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0017639:Gliosis [Pathologic Function]
   760   C0205234:Focal [Spatial Concept]
   760   C1282914:Surrounded [Spatial Concept]

Phrase: "These studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "indicate"

Phrase: "that"

Phrase: "the cross- structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "has"

Phrase: "direct effects on endothelial cells."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.58: Is the cross- structure then a common denominator in polypeptide fragments with antiangiogenic activity? 

Phrase: "Is"

Phrase: "the cross- structure then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:Structure [Spatial Concept]

Phrase: "a common denominator in polypeptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2825218:Denominator [Quantitative Concept]

Phrase: "fragments with antiangiogenic activity?"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0205177:Activity [Functional Concept]
   770   C0332255:fragment [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C0486805:Fragments [Body Substance]
   770   C0596087:antiangiogenic [Biologically Active Substance,Pharmacologic Substance]
   770   C1561536:*Activity [Idea or Concept]
   770   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.59: The tPA connection In general, denatured proteins can stimulate plasminogen activation by tissue-type plasminogen activator (tPA).39 Amyloid fibrils such as amyloid and prion protein markedly stimulate plasminogen activation by tPA.40, 41 We found that the presence of cross- structure is a prerequisite for tPA binding and for activation of plasminogen.37 We noticed that many antiangiogenic compounds, generated through proteolytic cleavage or denaturation, stimulate tPA-mediated plasminogen activation (Table 1). 

Phrase: "The tPA connection In general, denatured proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0449379:Connection [Intellectual Product]

Phrase: "can"

Phrase: "stimulate"

Phrase: "plasminogen activation by tissue-type plasminogen activator"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   831   C0032143:Plasminogen activator tissue type [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
           Tissue Plasminogen Activator
   800   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   778   C1622667:plasminogen activation [Molecular Function]
   774   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C1367553:PLASMINOGEN [Gene or Genome]
   748   C1879547:Activation [Activity]

Phrase: "(tPA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C1367553:PLASMINOGEN [Gene or Genome]

Phrase: ").39 Amyloid fibrils such as amyloid"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0225328:fibrils [Cell Component]
   719 E C1948066:Fibril [Physical Object]

Phrase: "and"

Phrase: "prion protein markedly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   901   C1418941:PRION PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "stimulate"

Phrase: "plasminogen activation by tPA.40,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1622667:plasminogen activation [Molecular Function]
   774   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C1367553:PLASMINOGEN [Gene or Genome]
   748   C1879547:Activation [Activity]

Phrase: "41"

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the presence of cross- structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "a prerequisite for tPA binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0679209:prerequisite [Idea or Concept]

Phrase: "and for activation of plasminogen.37"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C1622667:plasminogen activation [Molecular Function]
   753   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C1367553:PLASMINOGEN [Gene or Genome]
   753   C1515981:And [Idea or Concept]
   753   C1879547:Activation [Activity]

Phrase: "We"

Phrase: "noticed"

Phrase: "that"

Phrase: "many antiangiogenic compounds,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205198:Compound [Qualitative Concept]
   827   C1706082:Compound [Chemical]

Phrase: "generated through proteolytic cleavage"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C0597304:Proteolytic [Molecular Function]
   770   C1330957:cleavage [Cell Function]
   770   C1947941:proteolytic [Enzyme]
   770   C3146294:Generated [Activity]

Phrase: "or"

Phrase: "denaturation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0301642:Denaturation [Molecular Function]

Phrase: "stimulate"

Phrase: "tPA-mediated plasminogen activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   876   C1622667:plasminogen activation [Molecular Function]
   799   C1879547:Activation [Activity]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.60: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.61: Overview of antitumorigenic proteins with tPA-stimulating activity  Do antiangiogenic protein fragments have amyloid properties? 

Phrase: "Overview of antitumorigenic proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0814812:overview [Intellectual Product]

Phrase: "with tPA-stimulating activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   888   C1150269:plasminogen activator activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "Do"

Phrase: "antiangiogenic protein fragments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   884   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "have"

Phrase: "amyloid properties?"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]
Processing 00000000.tx.62: It is intriguing that unrelated proteins lacking sequence homology acquire antiangiogenic activity on proteolytic cleavage or denaturation and at the same time acquire the ability to stimulate tPA-mediated plasminogen activation. 

Phrase: "It"

Phrase: "is"

Phrase: "intriguing"

Phrase: "that unrelated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "sequence homology"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
  1000   C0162775:Sequence Homology [Quantitative Concept]
   950 E C0162774:Sequence Homolog [Molecular Sequence]
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1334043:Homology [Gene or Genome]
   861   C1519249:Sequence [Functional Concept]
   861   C2697616:Homology [Qualitative Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "acquire"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1706701:Acquire [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "antiangiogenic activity on proteolytic cleavage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "or"

Phrase: "denaturation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0301642:Denaturation [Molecular Function]

Phrase: "and at the same time"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0040223:Time [Temporal Concept]
   760   C0445247:Same [Qualitative Concept]
   760   C1515981:And [Idea or Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "acquire"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1706701:Acquire [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "stimulate"

Phrase: "tPA-mediated plasminogen activation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   876   C1622667:plasminogen activation [Molecular Function]
   799   C1879547:Activation [Activity]
Processing 00000000.tx.63: Toxicity of aggregates of denatured proteins is also independent of the amino acid sequence.23,27 Taken together, this suggests that a common antiangiogenic pathway may exist that is induced by tPA-binding proteins. 

Phrase: "Toxicity of aggregates of denatured proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0040539:toxicity [Qualitative Concept]
   753   C0600688:Toxicity [Injury or Poisoning]
   748   C0815048:toxic proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "also independent of the amino acid sequence.23,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   800   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   770   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0332291:Independent of [Functional Concept]
   770   C2917660:Amino Acid [Pharmacologic Substance]
   744   C0001128:Acid [Chemical]
   744   C0004793:Sequence [Nucleotide Sequence]
   744   C0085862:Independent [Idea or Concept]
   744   C0162326:Sequence [Nucleotide Sequence]
   744   C0162327:Sequence [Nucleotide Sequence]
   744   C0202406:Acid [Laboratory Procedure]
   744   C0450348:23 [Quantitative Concept]
   744   C1299583:Independent [Finding]
   744   C1519249:Sequence [Functional Concept]

Phrase: "27"

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "this"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a common antiangiogenic pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "may"

Phrase: "exist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: "that"

Phrase: "is"

Phrase: "induced by tPA-binding proteins."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   788   C2364020:Plasminogen-Binding Protein [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   778   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757 E C0033618:Protein Binding [Molecular Function]
   748   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205263:Induced [Functional Concept]
   748   C0243122:binding [Functional Concept]
   748   C0332307:Type [Qualitative Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1367553:PLASMINOGEN [Gene or Genome]
   748   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.64: We hypothesize that antiangiogenic polypeptide fragments contain the cross- structure and that this structure is the common denominator responsible for their antiangiogenic and antitumor effects. 

Phrase: "We"

Phrase: "hypothesize"

Phrase: "that antiangiogenic polypeptide fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the cross- structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "that"

Phrase: "this structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "is"

Phrase: "the common denominator"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2825218:Denominator [Quantitative Concept]

Phrase: "responsible for their antiangiogenic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "and"

Phrase: "antitumor effects."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1280500:effects [Qualitative Concept]
   861   C2986475:Antitumor [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.65: If correct, the presence of cross- structure in antiangiogenic proteins could represent yet another example of a physiologic function of protein aggregation as has been published recently for microbial and eukaryotic proteins (for a review, see Huff et al20). 

Phrase: "If"

Phrase: "correct,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349182:Correct [Qualitative Concept]

Phrase: "the presence of cross- structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in antiangiogenic proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "yet"

Phrase: "another example of a physiologic function of protein aggregation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1707959:Example [Conceptual Entity]

Phrase: "as"

Phrase: "has"

Phrase: "been"

Phrase: "published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: "recently for microbial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332185:Recently [Temporal Concept]
   790   C0599840:microbial [Organism]

Phrase: "and"

Phrase: "eukaryotic proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "for a review,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Huff et al20"

Phrase: ")."
Processing 00000000.tx.66: Potential mechanism of cytotoxicity Can tPA contribute to the antiangiogenic effects of these compounds?41 tPA is historically known for its role in blood clot lysis (fibrinolysis). 

Phrase: "Potential mechanism of cytotoxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "Can"

Phrase: "tPA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0332307:Type [Qualitative Concept]
   827   C1367553:PLASMINOGEN [Gene or Genome]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "contribute to the antiangiogenic effects of these compounds?41 tPA"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   753   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   736   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   736   C0332307:Type [Qualitative Concept]
   736   C0596087:antiangiogenic [Biologically Active Substance,Pharmacologic Substance]
   736   C1280500:effects [Qualitative Concept]
   736   C1367553:PLASMINOGEN [Gene or Genome]
   736   C1547052:*Type [Quantitative Concept]
   736   C1880177:Contribute [Activity]
   703   C0205198:Compound [Qualitative Concept]
   703   C1706082:Compound [Chemical]
   703 E C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "historically"

Phrase: "known for its role"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0035820:Role [Social Behavior]
   770   C0205309:Known [Qualitative Concept]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in blood clot lysis"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0024348:Lysis [Pathologic Function]
   827   C1536403:lysis [Cell Function]
   755 E C0439680:Lytic [Qualitative Concept]
   734   C0087086:blood clot [Pathologic Function]
   734   C0302148:Blood Clot [Acquired Abnormality]

Phrase: "(fibrinolysis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0016017:Fibrinolysis [Physiologic Function]
  1000   C1305868:Fibrinolysis [Laboratory Procedure]
   928 E C0040044:Fibrinolytic [Therapeutic or Preventive Procedure]

Phrase: ")."
Processing 00000000.tx.67: tPA cleaves the zymogen plasminogen into the active serine proteinase plasmin. 

Phrase: "tPA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C1367553:PLASMINOGEN [Gene or Genome]

Phrase: "cleaves"

Phrase: "the zymogen plasminogen into the active serine proteinase plasmin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C1367553:PLASMINOGEN [Gene or Genome]
Processing 00000000.tx.68: Pericellular plasmin subsequently degrades a fibrin clot. 

Phrase: "Pericellular plasmin subsequently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016016:Plasmin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "degrades"

Phrase: "a fibrin clot."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0009074:CLOT [Organic Chemical,Pharmacologic Substance]
   861   C0302148:Clot [Acquired Abnormality]
Processing 00000000.tx.69: Apart from their well-established role in clot lysis, tPA and plasmin also function in other processes, including long-term potentiation42 and neuronal cell migration.43 tPA has also been identified as a mediator of neuronal cell death following ischemia or excitotoxic injury in the brain.44 Intracerebral injection of excitotoxins such as glutamate and focal cerebral ischemia provoke degradation of the extracellular matrix protein laminin and cause neuronal death.45-47 We found that tPA activation by amyloid endostatin induced plasmin formation, degradation of the extracellular matrix protein vitronectin, and cell detachment.17 Matrix proteins including vitronectin, fibronectin, and laminin play an important role in cell survival48 and their breakdown can result in apoptosis. 

Phrase: "Apart from their well-established role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035820:Role [Social Behavior]
   827   C1705810:Role [Conceptual Entity]

Phrase: "in clot lysis,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0009074:CLOT [Organic Chemical,Pharmacologic Substance]
   861   C0024348:Lysis [Pathologic Function]
   861   C0302148:Clot [Acquired Abnormality]
   861   C1536403:lysis [Cell Function]
   789 E C0439680:Lytic [Qualitative Concept]

Phrase: "tPA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C1367553:PLASMINOGEN [Gene or Genome]

Phrase: "and"

Phrase: "plasmin also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016016:Plasmin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "function in other processes,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]
   737   C1184743:Process [Body Part, Organ, or Organ Component]
   737   C1522240:Process [Phenomenon or Process]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "long-term potentiation42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0443252:Long-term [Temporal Concept]

Phrase: "and"

Phrase: "neuronal cell migration.43 tPA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   818   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   795   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   795   C1367553:PLASMINOGEN [Gene or Genome]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "identified as a mediator of neuronal cell death"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   800   C2754100:neuronal cell death [Cell Function]
           neuron death
   770   C0007587:Cell Death [Cell Function]
   744   C0007634:Cell [Cell]
   744   C0011065:Death [Organism Function]
   744   C0205396:Identified [Qualitative Concept]
   744   C0521390:Neuronal [Immunologic Factor]
   744   C1269647:Cell [Cell]
   744   C1306577:Death, NOS [Finding]
   744   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1550043:Identified [Finding]
   744   C1551388:Identified [Functional Concept]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "ischemia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022116:Ischaemia [Disease or Syndrome]
   928 E C0475224:Ischaemic [Functional Concept]

Phrase: "or"

Phrase: "excitotoxic injury in the brain.44 Intracerebral injection of excitotoxins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C0270611:Brain Injury [Injury or Poisoning]
           Intracerebral injury
   739   C3263722:Injury [Injury or Poisoning]
   739   C3263723:Injury [Injury or Poisoning]

Phrase: "such as glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "focal cerebral ischemia"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0007785:Cerebral Ischemia [Disease or Syndrome]
   901   C0917798:Cerebral Ischemia [Disease or Syndrome]
   827   C0022116:Ischaemia [Disease or Syndrome]
   827   C0205234:Focal [Spatial Concept]
   755 E C0475224:Ischaemic [Functional Concept]
   755 E C1883677:Focality [Qualitative Concept]

Phrase: "provoke"

Phrase: "degradation of the extracellular matrix protein laminin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C1517052:Extracellular Matrix Degradation [Cell Function]
   774   C0597297:Protein Degradation [Molecular Function]
   774   C0597304:Protein Degradation [Molecular Function]
   774   C1623036:Protein Degradation [Molecular Function]
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "neuronal death.45-47"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   825   C2754100:neuron death [Cell Function]
   812   C0011065:Death [Organism Function]
   812   C0521390:Neuronal [Immunologic Factor]
   812   C1306577:Death, NOS [Finding]
   741 E C0027882:Neuron [Cell]

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that tPA activation by amyloid endostatin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1622667:plasminogen activation [Molecular Function]
   744   C1879547:Activation [Activity]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "plasmin formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "degradation of the extracellular matrix protein vitronectin,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C1517052:Extracellular Matrix Degradation [Cell Function]
   774   C0597297:Protein Degradation [Molecular Function]
   774   C0597304:Protein Degradation [Molecular Function]
   774   C1623036:Protein Degradation [Molecular Function]
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "cell detachment.17 Matrix proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C1383501:Cell Matrix [Cell Component]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1704640:Matrix [Spatial Concept]
   804   C1706515:Matrix [Body Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "vitronectin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0055023:Vitronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336937:VITRONECTIN [Gene or Genome]

Phrase: "fibronectin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "laminin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in cell survival48"

Phrase: "and"

Phrase: "their breakdown"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0443161:break down [Qualitative Concept]
  1000   C0699900:breakdown [Organism Function]
  1000   C1265875:breakdown [Acquired Abnormality]

Phrase: "can"

Phrase: "result in apoptosis."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0162638:Apoptosis [Cell Function]
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C2825142:Result [Finding]
   718 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.70: Induction of plasminogen activation leads to endothelial cell detachment,49 inhibition of cell adhesion,50 endothelial cell destruction,51 or regression of capillary tubes.52 Most recently, Angles-Cano and coworkers showed that plasminogen activation induces detachment and apoptosis of Chinese hamster ovary (CHO) fibroblasts53 and smooth muscle cells.54 tPA is constitutively expressed by CHO fibroblasts and smooth muscle cells and appears to be responsible for pericellular plasminogen activation.53,54 Finally, a possible role for tPA and plasmin in amyloid-mediated toxicity is further supported by the finding that serpins (a family of protease inhibitors) can inhibit amyloid toxicity. 

Phrase: "Induction of plasminogen activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "leads to endothelial cell detachment,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   806   C0225336:Endothelial cell [Cell]
   760   C0007634:Cell [Cell]
   760   C0014257:Endothelial [Tissue]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0181586:leads [Medical Device]
   760   C0541879:detachment [Mental Process]
   760   C0595950:Detachment [Pathologic Function]
   760   C1269647:Cell [Cell]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "49 inhibition of cell adhesion,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   926   C1516326:inhibition of cell adhesion [Cell Function]
           Cell Adhesion Inhibition
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "50 endothelial cell destruction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1261381:Destruction [Therapeutic or Preventive Procedure]
   812   C1948029:Destruction [Activity]

Phrase: "51"

Phrase: "or"

Phrase: "regression of capillary tubes.52 Most recently,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0684320:Regression [Pathologic Function]
   748   C0684321:Regression [Mental Process]

Phrase: "Angles-Cano"

Phrase: "and"

Phrase: "coworkers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681088:coworkers [Population Group]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that plasminogen activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1622667:plasminogen activation [Molecular Function]
   861   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1367553:PLASMINOGEN [Gene or Genome]
   861   C1879547:Activation [Activity]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "detachment"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0541879:detachment [Mental Process]
  1000   C0595950:Detachment [Pathologic Function]
   928 E C0687118:Detached [Functional Concept]
   928 E C1561504:detached [Idea or Concept]

Phrase: "and"

Phrase: "apoptosis of Chinese hamster ovary (CHO) fibroblasts53"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0162638:Apoptosis [Cell Function]

Phrase: "and"

Phrase: "smooth muscle cells.54 tPA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   818   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   795   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   795   C1367553:PLASMINOGEN [Gene or Genome]

Phrase: "is"

Phrase: "constitutively"

Phrase: "expressed by CHO fibroblasts"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0018555:Chinese Hamster [Mammal]
   753   C0008120:chinese [Language]
   753   C0016030:Fibroblasts [Cell]
   753   C0018557:Hamster [Mammal]
   753   C0029939:Ovary [Body Part, Organ, or Organ Component]
   753   C0152035:Chinese [Population Group]
   753   C0227898:ovary [Body Part, Organ, or Organ Component]
   753   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "smooth muscle cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
  1000   C1135918:Smooth Muscle Cells [Cell]
   901   C0596981:Muscle Cells [Cell]
   901   C1267092:Muscle, Smooth [Tissue]
   827   C0007634:Cells [Cell]
   827   C0026845:Muscle [Tissue]
   827   C0205357:Smooth [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "and"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "responsible for pericellular plasminogen activation.53,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1273518:Responsible [Finding]

Phrase: "54 Finally,"

Phrase: "a possible role for tPA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "plasmin in amyloid-mediated toxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0016016:Plasmin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "is"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "supported by the finding"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0037088:Finding [Sign or Symptom]
   770   C0243095:Finding [Finding]
   770   C1521721:Supported [Conceptual Entity]
   770   C2825141:Finding [Finding]
   737 E C0183683:Support [Medical Device]

Phrase: "that serpins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036764:Serpins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "("

Phrase: "a family of protease inhibitors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015576:Family [Family Group]
   760   C1704727:Family [Conceptual Entity]

Phrase: ")"

Phrase: "can"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "amyloid toxicity."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]
Processing 00000000.tx.71: Taken together, activation of tPA by amyloid polypeptides may induce excessive degradation of extracellular matrix with subsequent loss of cell attachment sites resulting in cell detachment and apoptosis. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "activation of tPA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1622667:plasminogen activation [Molecular Function]
   760   C1879547:Activation [Activity]

Phrase: "by amyloid polypeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]

Phrase: "may"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "excessive degradation of extracellular matrix"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C1517052:Extracellular Matrix Degradation [Cell Function]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "with subsequent loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517945:Loss [Quantitative Concept]

Phrase: "of cell attachment sites"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0887869:Cell Attachment [Cell Component]
   867   C0205675:Attachment site [Spatial Concept]
   827   C0185023:Attachment [Therapeutic or Preventive Procedure]
   827   C0205145:Sites [Spatial Concept]
   827   C1947904:Attachment [Activity]
   827   C1999228:Attachment [Intellectual Product]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "resulting"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0678226:resulting [Functional Concept]
   966 E C1274040:Result [Functional Concept]
   966 E C1546471:Result [Idea or Concept]
   966 E C2825142:Result [Finding]

Phrase: "in cell detachment"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0541879:detachment [Mental Process]
   827   C0595950:Detachment [Pathologic Function]
   755 E C0687118:Detached [Functional Concept]
   755 E C1561504:detached [Idea or Concept]

Phrase: "and"

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.72: If our hypothesis is correct, other cross- structure receptors in addition to tPA may mediate the antiangiogenic response. 

Phrase: "If"

Phrase: "our hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "is"

Phrase: "correct,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349182:Correct [Qualitative Concept]

Phrase: "other cross- structure receptors in addition to tPA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "may"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the antiangiogenic response."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]
Processing 00000000.tx.73: Good evidence indicates that at least 2 other receptors that bind amyloid polypeptides, CD36 and the receptor for advanced glycation end products (RAGE), could be involved.55,56 Many potential mechanisms for amyloid-induced cell toxicity have already been proposed. 

Phrase: "Good evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "indicates"

Phrase: "that at least 2"

Phrase: "other receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "that"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "amyloid polypeptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]

Phrase: "CD36"

Phrase: "and"

Phrase: "the receptor for advanced glycation end products (RAGE),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "could"

Phrase: "be"

Phrase: "involved.55,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450382:55 [Intellectual Product]
   861   C1314939:Involved [Functional Concept]

Phrase: "56"

Phrase: "Many potential mechanisms for amyloid-induced cell toxicity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0441712:Mechanisms [Functional Concept]
   711 E C1706376:Mechanism [Manufactured Object]

Phrase: "have"

Phrase: "already"

Phrase: "been"

Phrase: "proposed."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]
Processing 00000000.tx.74: It is well established that amyloid-induced neuronal cell toxicity involves the production of reactive oxygen species and disruption of calcium homeostasis. 

Phrase: "It"

Phrase: "is"

Phrase: "well established"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205170:Well [Qualitative Concept]
   861   C0443211:Established [Qualitative Concept]
   861   C1272684:Established [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "that amyloid-induced neuronal cell toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   804   C0040539:toxicity [Qualitative Concept]
   804   C0600688:Toxicity [Injury or Poisoning]
   733 E C1407029:Toxic [Qualitative Concept]
   711 E C0032346:Poison [Hazardous or Poisonous Substance]
   711 E C1548769:Poison [Intellectual Product]
   711 E C1550590:poison [Idea or Concept]

Phrase: "involves"

Phrase: "the production of reactive oxygen species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "disruption of calcium homeostasis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332453:Disruption [Functional Concept]
Processing 00000000.tx.75: Endothelial cell toxicity caused by A is also associated with the production of superoxide free radicals, causing oxidative lipid and protein damage, and increased intracellular calcium concentration.32,57,58 Implications If correct, our hypothesis implies that (1) it is relevant to look at structural properties of angiogenesis inhibitors, rather than at their primary amino acid sequence and to consider the possibility that an active drug requires a cross- structure; 

Phrase: "Endothelial cell toxicity"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0040539:toxicity [Qualitative Concept]
   827   C0600688:Toxicity [Injury or Poisoning]
   755 E C1407029:Toxic [Qualitative Concept]
   734 E C0032346:Poison [Hazardous or Poisonous Substance]
   734   C0225336:Endothelial cell [Cell]
   734 E C1548769:Poison [Intellectual Product]
   734 E C1550590:poison [Idea or Concept]

Phrase: "caused by A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]

Phrase: "is"

Phrase: "also"

Phrase: "associated with the production of superoxide free radicals,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   770   C0016693:Free Radicals [Biologically Active Substance,Chemical Viewed Structurally]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   750   C0038836:Superoxide Radical [Element, Ion, or Isotope]
           Superoxide
   744   C0033268:production [Occupational Activity]
   744   C0302912:radicals [Chemical Viewed Structurally]
   744   C0332296:free [Functional Concept]
   744   C1880497:Free [Qualitative Concept]
   744   C1996904:Free [Qualitative Concept]
   711 E C0439807:Radical [Qualitative Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "oxidative lipid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023779:Lipid [Lipid]

Phrase: "and"

Phrase: "protein damage,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010957:Damage [Injury or Poisoning]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1883709:Damage [Functional Concept]

Phrase: "and"

Phrase: "increased intracellular calcium concentration.32,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   853   C0553702:increased calcium [Finding]
   804   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   804   C0006726:Calcium [Inorganic Chemical]
   804   C0086045:Concentration [Mental Process]
   804   C0175996:intracellular [Cell Component]
   804   C0178719:Intracellular [Spatial Concept]
   804   C0205217:Increased [Quantitative Concept]
   804   C0442805:Increased [Functional Concept]
   804   C1446561:Concentration [Quantitative Concept]
   804   C2936886:Calcium [Pharmacologic Substance]
   733 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "57,"

Phrase: "58 Implications"

Phrase: "If"

Phrase: "correct,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349182:Correct [Qualitative Concept]

Phrase: "our hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "implies"

Phrase: "that"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "it"

Phrase: "is"

Phrase: "relevant to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347946:Relevant [Qualitative Concept]

Phrase: "look at structural properties of angiogenesis inhibitors,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   778   C0596087:Angiogenesis Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   748   C0233426:look [Organism Attribute]
   748   C0243077:inhibitors [Chemical Viewed Functionally]
   748   C0302600:Angiogenesis [Organ or Tissue Function]
   748   C0678594:Structural [Spatial Concept]
   748   C0871161:properties [Qualitative Concept]
   748   C1292721:properties [Functional Concept]
   748   C1519670:angiogenesis [Neoplastic Process]
   714 E C1882134:Property [Conceptual Entity]
   714 E C1999216:Inhibitor [Qualitative Concept]
   714 E C2347695:Property [Entity]

Phrase: "rather than at their primary amino acid sequence"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   800   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   800   C0682967:primary aminoacid [Amino Acid, Peptide, or Protein]
   770   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C2917660:Amino Acid [Pharmacologic Substance]
   744   C0001128:Acid [Chemical]
   744   C0004793:Sequence [Nucleotide Sequence]
   744   C0162326:Sequence [Nucleotide Sequence]
   744   C0162327:Sequence [Nucleotide Sequence]
   744   C0202406:Acid [Laboratory Procedure]
   744   C0205225:Primary [Qualitative Concept]
   744   C0439631:Primary [Therapeutic or Preventive Procedure]
   744   C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "consider"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:consider [Idea or Concept]

Phrase: "the possibility"

Phrase: "that"

Phrase: "an active drug"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0013227:Drug [Pharmacologic Substance]
   861   C1254351:Drug [Pharmacologic Substance]
   805 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   805 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   768 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "requires"

Phrase: "a cross- structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.76: (2) the inhibitory effect of the drugs listed in Table 1 may be improved by adding factors that are known to increase amyloid-mediated toxicity, such as lipopolysaccharide (LPS), tumor necrosis factor (TNF-), and interferon (IFN-)59,60; 

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "the inhibitory effect of the drugs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   820   C0728866:effect of drugs [Functional Concept]
           Drug effect
   767   C0728867:Drug effect [Pathologic Function]
   767   C1411996:drug effect [Biologic Function]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "listed in Table 1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C0745732:List [Conceptual Entity]
   737   C3272378:LIST [Intellectual Product]

Phrase: "may"

Phrase: "be"

Phrase: "improved by adding factors"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0184511:Improved [Qualitative Concept]
   770   C0332272:Improved [Qualitative Concept]
   770   C1561611:Improved [Intellectual Product]
   737   C1521761:Factor [Functional Concept]
   737   C1883712:Add [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "amyloid-mediated toxicity,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   827   C0040539:toxicity [Qualitative Concept]
   827   C0600688:Toxicity [Injury or Poisoning]
   755 E C1407029:Toxic [Qualitative Concept]
   734 E C0032346:Poison [Hazardous or Poisonous Substance]
   734 E C1548769:Poison [Intellectual Product]
   734 E C1550590:poison [Idea or Concept]

Phrase: "such as lipopolysaccharide (LPS),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023810:Lipopolysaccharide [Lipid]

Phrase: "tumor necrosis factor (TNF-),"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1323304:tumor necrosis factor [Molecular Function]
  1000   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0333516:Tumor necrosis [Neoplastic Process]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1334928:Necrosis [Finding]
   827   C1521761:Factor [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C3273930:Tumor [Finding]

Phrase: "and"

Phrase: "interferon (IFN-)59,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "60"

Phrase: ";"
Processing 00000000.tx.77: and (3) it is necessary to use these polypeptide fragments with caution because they may form toxic aggregates. 

Phrase: "and ("

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "it"

Phrase: "is"

Phrase: "necessary to"

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "these polypeptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "fragments with caution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332255:fragment [Functional Concept]
   790   C0486805:Fragments [Body Substance]
   790   C1708096:Fragment [Qualitative Concept]

Phrase: "because"

Phrase: "they"

Phrase: "may"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "toxic aggregates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]
Processing 00000000.tx.78: Moreover, tumor-derived endogenous circulating inhibitors may also possess cross- structure. 

Phrase: "Moreover,"

Phrase: "tumor-derived endogenous circulating inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0243077:inhibitors [Chemical Viewed Functionally]
   771 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "may"

Phrase: "also"

Phrase: "possess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "cross- structure."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]
Processing 00000000.tx.79: Besides their antiangiogenic activity, these circulating proteolytic fragments may, however, then also contribute to some of the clinical complications of cancer, such as amyloidosis or bleeding events. 

Phrase: "Besides their antiangiogenic activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "these circulating proteolytic fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "may"

Phrase: ","

Phrase: "however,"

Phrase: "then also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883708:Then [Temporal Concept]

Phrase: "contribute to some of the clinical complications of cancer,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   762   C0596237:cancer complications [Pathologic Function]
   742   C0006826:Cancer [Neoplastic Process]
   742   C0009566:Complications [Pathologic Function]
   742   C0205210:Clinical [Qualitative Concept]
   742   C0998265:Cancer [Eukaryote]
   742   C1171258:complications [Pathologic Function]
   742   C1306459:Cancer [Finding]
   742   C1880177:Contribute [Activity]
   708 E C2362589:Complication [Idea or Concept]

Phrase: "such as amyloidosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002726:Amyloidosis [Disease or Syndrome]

Phrase: "or"

Phrase: "bleeding events."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441471:Events [Event]
   861   C3541888:Events [Classification]
Processing 00000000.tx.80: Note added in proof. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "added in proof."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0556981:% proof [Quantitative Concept]
   790   C1524062:Added [Functional Concept]
   756 E C1883712:Add [Functional Concept]
Processing 00000000.tx.81: After this article was accepted for publication, we became aware of new results obtained by Paris et al.77 The authors showed that amyloid peptides inhibit angiogenesis. 

Phrase: "After this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "was"

Phrase: "accepted for publication,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1272684:Accepted [Qualitative Concept]
   790   C1548435:Accepted [Idea or Concept]
   790   C1704324:Publication [Intellectual Product]
   756 E C1548601:Accept [Idea or Concept]

Phrase: "we"

Phrase: "became"

Phrase: "aware of new results"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0004448:Aware [Mental Process]

Phrase: "obtained by Paris et al.77"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0030561:Paris [Geographic Area]
   753   C0331677:Paris [Plant]
   753   C1301820:Obtained [Functional Concept]
   753   C1824032:PARIS [Gene or Genome]
   719 E C1706701:Obtain [Activity]
   719 E C1824369:PARI [Gene or Genome]

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that amyloid peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "angiogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0302600:Angiogenesis [Organ or Tissue Function]
  1000   C1519670:angiogenesis [Neoplastic Process]
Processing 00000000.tx.82: Their results add amyloid peptides to the list of angiogenesis inhibitors that interact with tPA, and support our hypothesis that antiangiogenic fragments in general may have amyloid properties.  

Phrase: "Their results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "add"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883712:Add [Functional Concept]

Phrase: "amyloid peptides to the list of angiogenesis inhibitors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "interact with tPA,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0332307:Type [Qualitative Concept]
   760   C1367553:PLASMINOGEN [Gene or Genome]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "our hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that antiangiogenic fragments in general"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0332255:fragments [Functional Concept]
   760   C0486805:Fragments [Body Substance]
   726 E C1708096:Fragment [Qualitative Concept]

Phrase: "may"

Phrase: "have"

Phrase: "amyloid properties."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]
Processing 00000000.tx.83: Footnotes  Submitted February 5, 2004; 

Phrase: "Footnotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825232:Footnote [Intellectual Product]

Phrase: "Submitted February 5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1515023:Submitted [Functional Concept]

Phrase: "2004"

Phrase: ";"
Processing 00000000.tx.84: accepted May 7, 2004. 

Phrase: "accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "May 7,"

Phrase: "2004."
Processing 00000000.tx.85: Footnotes Prepublished online as Blood First Edition Paper, May 27, 2004; 

Phrase: "Footnotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825232:Footnote [Intellectual Product]

Phrase: "Prepublished online as Blood First Edition Paper,"

Phrase: "May 27,"

Phrase: "2004"

Phrase: ";"
Processing 00000000.tx.86: DOI 10.1182/blood-2004-02-0433. 

Phrase: "DOI 10.1182/blood-2004-02-0433."
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   795   C0005767:Blood [Tissue]
   795   C0005768:blood [Body Substance]
   795   C0229664:Blood [Body Substance]
   795   C2348291:DOI [Classification]
   724 E C0333275:Bloody [Qualitative Concept]
   712 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   712 E C0392895:Bloods [Population Group]
   712 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   712 E C1511228:VESSEL, BLOOD [Tissue]
Processing 00000000.tx.87: Supported by the Dutch Cancer Society (UU1999-2114). 

Phrase: "Supported by the Dutch Cancer Society"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0006826:Cancer [Neoplastic Process]
   753   C0013331:Dutch [Population Group]
   753   C0037455:society [Organization]
   753   C0998265:Cancer [Eukaryote]
   753   C1306459:Cancer [Finding]
   753   C1521721:Supported [Conceptual Entity]
   719 E C0183683:Support [Medical Device]

Phrase: "(UU1999-2114"

Phrase: ")."
Processing 00000000.tx.88: Reprints: Martijn F. 

Phrase: "Reprints"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3273171:Reprint [Intellectual Product]

Phrase: ":"

Phrase: "Martijn F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.89: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.90: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.91: Gebbink, Department of Hematology, G03.647, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands; 

Phrase: "Gebbink,"

Phrase: "Department of Hematology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0587491:Haematology department [Health Care Related Organization]
   790   C1704729:Department [Organization]

Phrase: "G03.647,"

Phrase: "University Medical Centre Utrecht,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]

Phrase: "Heidelberglaan 100,"

Phrase: "3584 CX Utrecht,"

Phrase: "The Netherlands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027778:The Netherlands [Geographic Area]
           Netherlands

Phrase: ";"
Processing 00000000.tx.92: e-mail: m.gebbink{at}azu.nl . References Carmeliet P, Jain RK. 

Phrase: "e-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "m."

Phrase: "gebbink{at}azu.nl ."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0027778:NL [Geographic Area]
   812   C0560008:nL [Quantitative Concept]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Carmeliet P,"

Phrase: "Jain RK."
Processing 00000000.tx.93: Angiogenesis in cancer and other diseases. 

Phrase: "Angiogenesis in cancer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C1536999:cancer angiogenesis [Neoplastic Process]
   790   C0302600:Angiogenesis [Organ or Tissue Function]
   790   C1519670:angiogenesis [Neoplastic Process]

Phrase: "and"

Phrase: "other diseases."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Diseases [Disease or Syndrome]
   928 E C1836721:MALS [Finding]
   928 E C3538764:MALS [Gene or Genome]
   928 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.94: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.95: 2000;407: 249-257.[CrossRef][Medline] [OrderarticleviaInfotrieve] Folkman J. 

Phrase: "2000"

Phrase: ";407"

Phrase: ":"

Phrase: "249-257."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Folkman J."
Processing 00000000.tx.96: Tumor angiogenesis: therapeutic implications. 

Phrase: "Tumor angiogenesis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1519670:Tumor Angiogenesis [Neoplastic Process]
           angiogenesis
   861   C0027651:Tumor [Neoplastic Process]
   861   C0302600:Angiogenesis [Organ or Tissue Function]
   861   C1578706:Tumor [Intellectual Product]
   861   C3273930:Tumor [Finding]

Phrase: ":"

Phrase: "therapeutic implications."
Processing 00000000.tx.97: N Engl J Med. 

Phrase: "N Engl J Med."
Processing 00000000.tx.98: 1971;285: 1182-1186.[Medline] [OrderarticleviaInfotrieve] O'Reilly MS, Holmgren L, Shing Y, et al. 

Phrase: "1971"

Phrase: ";285"

Phrase: ":"

Phrase: "1182-1186."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] O'Reilly MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   827   C2349943:Ms. [Conceptual Entity]
   827   C3539704:MS [Gene or Genome]

Phrase: "Holmgren L,"

Phrase: "Shing Y,"

Phrase: "et al."
Processing 00000000.tx.99: Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. 

Phrase: "Angiostatin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0290149:Angiostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ":"

Phrase: "a novel angiogenesis inhibitor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0596087:Angiogenesis inhibitor [Biologically Active Substance,Pharmacologic Substance]
   827   C0302600:Angiogenesis [Organ or Tissue Function]
   827   C1519670:angiogenesis [Neoplastic Process]
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "that"

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the suppression of metastases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   898   C1513178:Suppression of Metastasis [Cell Function]
           Metastasis Suppression
   770   C0221103:Suppression [Pathologic Function]
   770   C0301625:Suppression [Organism Function]
   770   C0439181:% suppression [Quantitative Concept]
   770   C0728721:suppression [Mental Process]

Phrase: "by a Lewis lung carcinoma."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0243038:Carcinoma, Lewis Lung [Experimental Model of Disease,Neoplastic Process]
   901   C0684249:Lung Carcinoma [Neoplastic Process]
   827   C0007097:Carcinoma [Neoplastic Process]
   827   C0024109:Lung [Body Part, Organ, or Organ Component]
   827   C0819757:LUNG [Tissue]
   827   C1278908:Lung [Body Part, Organ, or Organ Component]
   771 E C2707265:Pulmonary [Clinical Attribute]
   771 E C2709248:Pulmonary [Qualitative Concept]
   734 E C0032285:Pneumonia [Disease or Syndrome]
Processing 00000000.tx.100: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.101: 1994;79: 315-328.[Medline] [OrderarticleviaInfotrieve] O'Reilly MS, Boehm T, Shing Y, et al. 

Phrase: "1994"

Phrase: ";79"

Phrase: ":"

Phrase: "315-328."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] O'Reilly MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   827   C2349943:Ms. [Conceptual Entity]
   827   C3539704:MS [Gene or Genome]

Phrase: "Boehm T,"

Phrase: "Shing Y,"

Phrase: "et al."
Processing 00000000.tx.102: Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. 

Phrase: "Endostatin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0534628:Endostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1332771:endostatin [Gene or Genome]
  1000   C1705207:Endostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ":"

Phrase: "an endogenous inhibitor of angiogenesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0596087:Angiogenesis inhibitor [Biologically Active Substance,Pharmacologic Substance]
   760   C0205227:Endogenous [Functional Concept]
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "tumor growth."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0598934:tumor growth [Neoplastic Process]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0027651:Tumor [Neoplastic Process]
   861   C0220844:growth [Physiologic Function]
   861   C1578706:Tumor [Intellectual Product]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   861   C3273930:Tumor [Finding]
Processing 00000000.tx.103: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.104: 1997;88: 277-285.[Medline] [OrderarticleviaInfotrieve] Rhim TY, Park CS, Kim E, Kim SS. 

Phrase: "1997"

Phrase: ";88"

Phrase: ":"

Phrase: "277-285."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Rhim TY,"

Phrase: "Park CS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540510:cs [Quantitative Concept]

Phrase: "Kim E,"

Phrase: "Kim SS."
Processing 00000000.tx.105: Human prothrombin fragment 1 and 2 inhibit bFGF-induced BCE cell growth. 

Phrase: "Human prothrombin fragment 1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0072435:prothrombin fragment 1 [Amino Acid, Peptide, or Protein]
   812   C0033706:Prothrombin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]
   812   C2828369:Prothrombin [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "bFGF-induced BCE cell growth."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0007595:Cell Growth [Cell Function]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2911660:Growth [Activity]
Processing 00000000.tx.106: Biochem Biophys Res Commun. 

Phrase: "Biochem Biophys Res"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347379:RES [Finding]

Phrase: "Commun."
Processing 00000000.tx.107: 1998;252: 513-516.[CrossRef][Medline] [OrderarticleviaInfotrieve] O'Reilly MS, Pirie-Shepherd S, Lane WS, Folkman J. 

Phrase: "1998"

Phrase: ";252"

Phrase: ":"

Phrase: "513-516."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] O'Reilly MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   827   C2349943:Ms. [Conceptual Entity]
   827   C3539704:MS [Gene or Genome]

Phrase: "Pirie-Shepherd S,"

Phrase: "Lane WS,"

Phrase: "Folkman J."
Processing 00000000.tx.108: Antiangiogenic activity of the cleaved conformation of the serpin antithrombin. 

Phrase: "Antiangiogenic activity of the cleaved conformation of the serpin antithrombin."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   757   C0200416:Antithrombin Activity [Laboratory Procedure]
   757   C1152590:serpin activity [Molecular Function]
   757   C1152593:serpin activity [Molecular Function]
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.109: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.110: 1999;285: 1926-1928.[Abstract/Free FullText] Brown NJ, Staton CA, Rodgers GR, et al. 

Phrase: "1999"

Phrase: ";285"

Phrase: ":"

Phrase: "1926-1928."

Phrase: "[Abstract/Free FullText"

Phrase: "] Brown NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Staton CA,"

Phrase: "Rodgers GR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552950:[gr] [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.111: Fibrinogen E fragment selectively disrupts the vasculature and inhibits the growth of tumours in a syngeneic murine model. 

Phrase: "Fibrinogen E"

Phrase: "fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "selectively"

Phrase: "disrupts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "the vasculature"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005839:vasculature [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the growth of tumours"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0018270:'growth' NOS [Organism Function]
   770   C0220844:growth [Physiologic Function]
   770   C1621966:Growth [Organ or Tissue Function]
   770   C2911660:Growth [Activity]

Phrase: "in a syngeneic murine model."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3161035:Model [Intellectual Product]
Processing 00000000.tx.112: Br J Cancer. 

Phrase: "Br J Cancer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006826:Cancer [Neoplastic Process]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]
Processing 00000000.tx.113: 2002;86: 1813-1816.[CrossRef][Medline] [OrderarticleviaInfotrieve] Herbst RS, Hess KR, Tran HT, et al. 

Phrase: "2002"

Phrase: ";86"

Phrase: ":"

Phrase: "1813-1816."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Herbst RS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539879:RS [Idea or Concept]

Phrase: "Hess KR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022773:KR [Geographic Area]

Phrase: "Tran HT,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0018510:HT [Geographic Area]
   861   C0677607:HT [Disease or Syndrome]

Phrase: "et al."
Processing 00000000.tx.114: Phase I study of recombinant human endostatin in patients with advanced solid tumors. 

Phrase: "Phase I study of recombinant human endostatin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   814   C0920321:Phase I Study [Research Activity]
   774   C0178693:human study [Research Activity]
   748   C0557651:Study [Manufactured Object]
   748   C2603343:Study [Research Activity]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with advanced solid tumors."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C0280100:solid tumors [Neoplastic Process]
   827   C0027651:Tumors [Neoplastic Process]
   827   C0205208:Solid [Qualitative Concept]
   827   C0302909:Solid [Substance]
   827   C1378566:Solid [Biomedical or Dental Material]
   793 E C1578706:Tumor [Intellectual Product]
   793 E C3273930:Tumor [Finding]
Processing 00000000.tx.115: J Clin Oncol. 

Phrase: "J Clin Oncol."
Processing 00000000.tx.116: 2002;20: 3792-3803.[Abstract/Free FullText] Beerepoot LV, Witteveen PO, Groenewegen G, et al. 

Phrase: "2002"

Phrase: ";20"

Phrase: ":"

Phrase: "3792-3803."

Phrase: "[Abstract/Free FullText"

Phrase: "] Beerepoot LV,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0023128:LV [Geographic Area]
   861   C0731033:LV [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C1881413:LV [Chemical Viewed Structurally]

Phrase: "Witteveen PO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442027:PO [Spatial Concept]

Phrase: "Groenewegen G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.117: Recombinant human angiostatin by twice-daily subcutaneous injection in advanced cancer: a pharmacokinetic and long-term safety study. 

Phrase: "Recombinant human angiostatin by twice-daily subcutaneous injection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0290149:Angiostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "in advanced cancer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0877373:Advanced Cancer [Neoplastic Process]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]

Phrase: ":"

Phrase: "a pharmacokinetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201734:PHARMACOKINETIC [Research Activity]

Phrase: "and"

Phrase: "long-term safety study."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0023981:long-term study [Research Activity]
   861   C1705187:Safety Study [Research Activity]
   812   C0557651:Study [Manufactured Object]
   812   C2603343:Study [Research Activity]
Processing 00000000.tx.118: Clin Cancer Res. 

Phrase: "Clin Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347379:RES [Finding]
Processing 00000000.tx.119: 2003;9: 4025-4033.[Abstract/Free FullText] Gordon MS, Mendelson D, Guirguis MS, et al. 

Phrase: "2003"

Phrase: ";9"

Phrase: ":"

Phrase: "4025-4033."

Phrase: "[Abstract/Free FullText"

Phrase: "] Gordon MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "Mendelson D,"

Phrase: "Guirguis MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "et al."
Processing 00000000.tx.120: ABT-510, an antiangiogenic, thrombospondin-1 (TSP-1) mimetic peptide, exhibits favorable safety profile and early signals of activity in a randomized phase IB trial [abstract]. 

Phrase: "ABT-510,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704426:ABT-510 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0045246:abt [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "an antiangiogenic, thrombospondin-1 (TSP-1) mimetic peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "favorable safety profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1979963:Profile [Laboratory Procedure]
   827   C2003903:Profile [Functional Concept]

Phrase: "and"

Phrase: "early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "signals of activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0205177:Activity [Functional Concept]
   790   C0439167:% activity [Quantitative Concept]
   790   C0441655:Activity [Activity]
   790   C1561536:*Activity [Idea or Concept]
   790   C1710082:Signal [Phenomenon or Process]

Phrase: "in a randomized phase IB trial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0008976:Trial [Research Activity]

Phrase: "[abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.121: Proceedings of the Thirty-ninth Annual Meeting of the American Society of Clinical Oncology, May 31-June 3, 2003; 

Phrase: "Proceedings of the Thirty-ninth Annual Meeting"

Phrase: "of the American Society of Clinical Oncology,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1515948:American Society of Clinical Oncology [Professional Society]
   840   C1274034:Clinical Oncology [Biomedical Occupation or Discipline]
   804   C0037455:society [Organization]
   804   C0205210:Clinical [Qualitative Concept]
   804   C0278627:Oncology [Biomedical Occupation or Discipline]
   804   C0596070:American [Population Group]
   733 E C0205478:Oncologic [Biomedical Occupation or Discipline]

Phrase: "May 31-June 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0450355:31 [Intellectual Product]

Phrase: "2003"

Phrase: ";"
Processing 00000000.tx.122: Chicago, IL. 

Phrase: "Chicago,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008044:Chicago [Geographic Area]

Phrase: "IL."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]
Processing 00000000.tx.123: 2003: 195. 

Phrase: "2003"

Phrase: ":"

Phrase: "195."
Processing 00000000.tx.124: Abstract 780. 

Phrase: "Abstract 780."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0000857:Abstract [Occupational Activity]
   861   C0600678:Abstract [Intellectual Product]
   861   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.125: Boehm T, Folkman J, Browder T, O'Reilly MS. 

Phrase: "Boehm T,"

Phrase: "Folkman J,"

Phrase: "Browder T,"

Phrase: "O'Reilly MS."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   827   C2349943:Ms. [Conceptual Entity]
   827   C3539704:MS [Gene or Genome]
Processing 00000000.tx.126: Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. 

Phrase: "Antiangiogenic therapy of experimental cancer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0920425:Cancer Therapy [Therapeutic or Preventive Procedure]
   797   C0949266:Therapy, Experimental [Therapeutic or Preventive Procedure]
   760   C0039798:therapy [Functional Concept]
   760   C0087111:Therapy [Therapeutic or Preventive Procedure]
   760   C1363945:Therapy [Finding]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "acquired drug resistance."
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
   901   C0013203:Drug resistance [Biologic Function]
   827   C0013227:Drug [Pharmacologic Substance]
   827   C0237834:Resistance [Mental Process]
   827   C1254351:Drug [Pharmacologic Substance]
   827   C1514892:Resistance [Physiologic Function]
   771 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   771 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   755 E C0332325:Resistant [Functional Concept]
   755 E C1550464:resistent [Idea or Concept]
   755 E C2827757:RESISTANT [Laboratory or Test Result]
   734 E C0456386:Medicament [Pharmacologic Substance]
Processing 00000000.tx.127: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.128: 1997;390: 404-407.[CrossRef][Medline] [OrderarticleviaInfotrieve] Marshall E. 

Phrase: "1997"

Phrase: ";390"

Phrase: ":"

Phrase: "404-407."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Marshall E."
Processing 00000000.tx.129: Cancer therapy. 

Phrase: "Cancer therapy."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0920425:Cancer Therapy [Therapeutic or Preventive Procedure]
   861   C0039798:therapy [Functional Concept]
   861   C0087111:Therapy [Therapeutic or Preventive Procedure]
   861   C1363945:Therapy [Finding]
Processing 00000000.tx.130: Setbacks for endostatin. 

Phrase: "Setbacks for endostatin."
Processing 00000000.tx.131: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.132: 2002;295: 2198-2199.[Free FullText] Steele FR. 

Phrase: "2002"

Phrase: ";295"

Phrase: ":"

Phrase: "2198-2199."

Phrase: "[Free FullText"

Phrase: "] Steele FR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2348513:Fr. [Conceptual Entity]
   861   C3538902:FR [Gene or Genome]
Processing 00000000.tx.133: Can "negative" be positive? 

Phrase: "Can """

Phrase: "negative"""
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205160:Negative [Qualitative Concept]
  1000   C1513916:Negative [Finding]
  1000   C2825415:Negative [Conceptual Entity]
  1000   C2825491:Negative [Qualitative Concept]

Phrase: "be"

Phrase: "positive?"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439178:% Positive [Quantitative Concept]
  1000   C1446409:Positive [Qualitative Concept]
  1000   C1514241:Positive [Finding]
  1000   C2825490:Positive [Qualitative Concept]
Processing 00000000.tx.134: Mol Ther. 

Phrase: "Mol Ther."
Processing 00000000.tx.135: 2002;5: 338-339.[CrossRef][Medline] [OrderarticleviaInfotrieve] Eisterer W, Jiang X, Bachelot T, et al. 

Phrase: "2002"

Phrase: ";5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ":"

Phrase: "338-339."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Eisterer W,"

Phrase: "Jiang X,"

Phrase: "Bachelot T,"

Phrase: "et al."
Processing 00000000.tx.136: Unfulfilled promise of endostatin in a gene therapy-xenotransplant model of human acute lymphocytic leukemia. 

Phrase: "Unfulfilled promise of endostatin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1555307:promise [Idea or Concept]

Phrase: "in a gene therapy-xenotransplant model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3161035:Model [Intellectual Product]

Phrase: "of human acute lymphocytic leukemia."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0023449:Acute lymphocytic leukaemia [Neoplastic Process]
   923   C1961102:Lymphocytic Leukemia, Acute [Neoplastic Process]
   875   C0085669:Acute leukaemia [Neoplastic Process]
   875   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   861   C0023448:Lymphocytic Leukemia [Neoplastic Process]
   812   C0023418:Leukaemia [Neoplastic Process]
   812   C0024264:Lymphocytic [Cell]
   812   C0205178:acute [Temporal Concept]
   812   C2939172:Lymphocytic [Qualitative Concept]
Processing 00000000.tx.137: Mol Ther. 

Phrase: "Mol Ther."
Processing 00000000.tx.138: 2002;5: 352-359.[CrossRef][Medline] [OrderarticleviaInfotrieve] Pawliuk R, Bachelot T, Zurkiya O, et al. 

Phrase: "2002"

Phrase: ";5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ":"

Phrase: "352-359."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Pawliuk R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Bachelot T,"

Phrase: "Zurkiya O,"

Phrase: "et al."
Processing 00000000.tx.139: Continuous intravascular secretion of endostatin in mice from transduced hematopoietic stem cells. 

Phrase: "Continuous intravascular secretion of endostatin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "from transduced hematopoietic stem cells."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   923   C0018956:Hematopoietic stem cells [Cell]
   861   C0038250:Stem cells [Cell]
   858   C2323499:Hematopoietic cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0018957:Haematopoietic [Body System]
   812   C0229601:Hematopoietic [Functional Concept]
   812   C0242767:Stem [Plant]
   812   C1186763:Stem [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   741 E C0018951:Haematopoiesis [Organ or Tissue Function]
Processing 00000000.tx.140: Mol Ther. 

Phrase: "Mol Ther."
Processing 00000000.tx.141: 2002;5: 345-351.[CrossRef][Medline] [OrderarticleviaInfotrieve] Jouanneau E, Alberti L, Nejjari M, et al. 

Phrase: "2002"

Phrase: ";5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ":"

Phrase: "345-351."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Jouanneau E,"

Phrase: "Alberti L,"

Phrase: "Nejjari M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.142: Lack of antitumor activity of recombinant endostatin in a human neuroblastoma xenograft model. 

Phrase: "Lack of antitumor activity of recombinant endostatin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332268:lack [Qualitative Concept]

Phrase: "in a human neuroblastoma xenograft model."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1520166:Xenograft Model [Experimental Model of Disease]
   812   C3161035:Model [Intellectual Product]
Processing 00000000.tx.143: J Neurooncol. 

Phrase: "J Neurooncol."
Processing 00000000.tx.144: 2001;51: 11-18.[CrossRef][Medline] [OrderarticleviaInfotrieve] Reijerkerk A, Mosnier LO, Kranenburg O, et al. 

Phrase: "2001"

Phrase: ";51"

Phrase: ":"

Phrase: "11-18."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Reijerkerk A,"

Phrase: "Mosnier LO,"

Phrase: "Kranenburg O,"

Phrase: "et al."
Processing 00000000.tx.145: Amyloid endostatin induces endothelial cell detachment by stimulation of the plasminogen activation system. 

Phrase: "Amyloid endostatin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0534628:Endostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C1332771:endostatin [Gene or Genome]
   861   C1705207:Endostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "endothelial cell detachment by stimulation of the plasminogen activation system."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0541879:detachment [Mental Process]
   739   C0595950:Detachment [Pathologic Function]
Processing 00000000.tx.146: Mol Cancer Res. 

Phrase: "Mol Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347379:RES [Finding]
Processing 00000000.tx.147: 2003;1: 561-568.[Abstract/Free FullText] Kranenburg O, Kroon-Batenburg LM, Reijerkerk A, et al. 

Phrase: "2003"

Phrase: ";1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "561-568."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kranenburg O,"

Phrase: "Kroon-Batenburg LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1261082:LM [Body Part, Organ, or Organ Component]
   827   C1551056:lm [Quantitative Concept]
   827   C2981682:LM [Quantitative Concept]

Phrase: "Reijerkerk A,"

Phrase: "et al."
Processing 00000000.tx.148: Recombinant endostatin forms amyloid fibrils that bind and are cytotoxic to murine neuroblastoma cells in vitro. 

Phrase: "Recombinant endostatin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1705207:Recombinant Endostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Endostatin
   861   C0534628:Endostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C1332771:endostatin [Gene or Genome]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "amyloid fibrils"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0225328:fibrils [Cell Component]
   827 E C1948066:Fibril [Physical Object]

Phrase: "that"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "and"

Phrase: "are"

Phrase: "cytotoxic to murine neuroblastoma cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0022686:Cytotoxic cell [Cell]
   760   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   760   C1511636:cytotoxic [Functional Concept]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.149: FEBS Lett. 

Phrase: "FEBS Lett."
Processing 00000000.tx.150: 2003;539: 149-155.[CrossRef][Medline] [OrderarticleviaInfotrieve] Selkoe DJ. 

Phrase: "2003"

Phrase: ";539"

Phrase: ":"

Phrase: "149-155."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Selkoe DJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]
Processing 00000000.tx.151: Folding proteins in fatal ways. 

Phrase: "Folding proteins in fatal ways."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0162847:folding protein [Molecular Function]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.152: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.153: 2003;426: 900-904.[CrossRef][Medline] [OrderarticleviaInfotrieve] Huff ME, Balch WE, Kelly JW. 

Phrase: "2003"

Phrase: ";426"

Phrase: ":"

Phrase: "900-904."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Huff"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0566520:huff [Finding]

Phrase: "ME,"

Phrase: "Balch"

Phrase: "WE,"

Phrase: "Kelly JW."
Processing 00000000.tx.154: Pathological and functional amyloid formation orchestrated by the secretory pathway. 

Phrase: "Pathological"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0030664:Pathological [Biomedical Occupation or Discipline]
  1000   C1521733:Pathological [Functional Concept]
   928 E C0205469:pathology [Functional Concept]
   928 E C0677042:pathology [Pathologic Function]

Phrase: "and"

Phrase: "functional amyloid formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "orchestrated by the secretory pathway."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1159342:Secretory Pathway [Cell Function]
   760   C1327616:Secretory [Cell Function]
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.155: Curr Opin Struct Biol. 

Phrase: "Curr Opin Struct Biol."
Processing 00000000.tx.156: 2003;13: 674-682.[CrossRef][Medline] [OrderarticleviaInfotrieve] Kelly JW, Balch WE. 

Phrase: "2003"

Phrase: ";13"

Phrase: ":"

Phrase: "674-682."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kelly JW,"

Phrase: "Balch"

Phrase: "WE."
Processing 00000000.tx.157: Amyloid as a natural product. 

Phrase: "Amyloid as a natural product."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0002723:Amyloid A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.158: J Cell Biol. 

Phrase: "J Cell Biol."
Processing 00000000.tx.159: 2003;161: 461-462.[Abstract/Free FullText] Dobson CM. 

Phrase: "2003"

Phrase: ";161"

Phrase: ":"

Phrase: "461-462."

Phrase: "[Abstract/Free FullText"

Phrase: "] Dobson CM."
Processing 00000000.tx.160: Protein folding and misfolding. 

Phrase: "Protein folding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162847:protein folding [Molecular Function]
   861   C0185026:Folding [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "misfolding."
Processing 00000000.tx.161: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.162: 2003;426: 884-890.[CrossRef][Medline] [OrderarticleviaInfotrieve] Bucciantini M, Giannoni E, Chiti F, et al. 

Phrase: "2003"

Phrase: ";426"

Phrase: ":"

Phrase: "884-890."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bucciantini M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Giannoni E,"

Phrase: "Chiti F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.163: Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. 

Phrase: "Inherent toxicity of aggregates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040539:toxicity [Qualitative Concept]
   770   C0600688:Toxicity [Injury or Poisoning]

Phrase: "implies"

Phrase: "a common mechanism for protein misfolding diseases."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.164: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.165: 2002;416: 507-511.[CrossRef][Medline] [OrderarticleviaInfotrieve] Hardy J, Selkoe DJ. 

Phrase: "2002"

Phrase: ";416"

Phrase: ":"

Phrase: "507-511."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450381:507 [Intellectual Product]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hardy J,"

Phrase: "Selkoe DJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]
Processing 00000000.tx.166: The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. 

Phrase: "The amyloid hypothesis of Alzheimer's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1512571:Hypothesis [Idea or Concept]

Phrase: ":"

Phrase: "progress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1272688:progress [Functional Concept]
  1000   C1280477:Progress [Functional Concept]

Phrase: "and"

Phrase: "problems on the road"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1546466:Problems [Idea or Concept]
   737 E C0033213:Problem [Finding]

Phrase: "to therapeutics."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039796:Therapeutics [Therapeutic or Preventive Procedure]
  1000   C0723712:therapeutics [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.167: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.168: 2002;297: 353-356.[Abstract/Free FullText] Kirkitadze MD, Bitan G, Teplow DB. 

Phrase: "2002"

Phrase: ";297"

Phrase: ":"

Phrase: "353-356."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kirkitadze MD,"

Phrase: "Bitan G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Teplow DB."
Processing 00000000.tx.169: Paradigm shifts in Alzheimer's disease and other neurode-generative disorders: the emerging role of oligomeric assemblies. 

Phrase: "Paradigm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681797:paradigm [Research Activity]

Phrase: "shifts in Alzheimer's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0333051:Shift [Functional Concept]
   770   C2347509:Shift [Phenomenon or Process]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "other neurode-generative disorders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012634:Disorders [Disease or Syndrome]

Phrase: ":"

Phrase: "the emerging role of oligomeric assemblies."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.170: J Neurosci Res. 

Phrase: "J Neurosci Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347379:RES [Finding]
Processing 00000000.tx.171: 2002;69: 567-577.[CrossRef][Medline] [OrderarticleviaInfotrieve] Walsh DM, Klyubin I, Fadeeva JV, et al. 

Phrase: "2002"

Phrase: ";69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: ":"

Phrase: "567-577."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Walsh DM,"

Phrase: "Klyubin I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Fadeeva JV,"

Phrase: "et al."
Processing 00000000.tx.172: Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. 

Phrase: "Naturally secreted oligomers of amyloid beta protein potently"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "hippocampal long-term potentiation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0206249:Long-Term Potentiation [Organ or Tissue Function]
   923   C2984294:Long-term potentiation [Functional Concept]
   861   C0443252:Long-term [Temporal Concept]
   812   C0205166:Long [Qualitative Concept]
   812   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   812   C1515273:Term [Temporal Concept]
   812   C1705313:Term [Idea or Concept]
   812   C1706317:Long [Qualitative Concept]
   812   C2826302:TERM [Intellectual Product]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.173: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.174: 2002;416: 535-539.[CrossRef][Medline] [OrderarticleviaInfotrieve] Kayed R, Head E, Thompson JL, et al. 

Phrase: "2002"

Phrase: ";416"

Phrase: ":"

Phrase: "535-539."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kayed R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Head E,"

Phrase: "Thompson JL,"

Phrase: "et al."
Processing 00000000.tx.175: Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. 

Phrase: "Common structure of soluble amyloid oligomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678594:Structure [Spatial Concept]

Phrase: "implies"

Phrase: "common mechanism of pathogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.176: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.177: 2003;300: 486-489.[Abstract/Free FullText] Deli MA, Sakaguchi S, Nakaoke R, et al. 

Phrase: "2003"

Phrase: ";300"

Phrase: ":"

Phrase: "486-489."

Phrase: "[Abstract/Free FullText"

Phrase: "] Deli MA,"

Phrase: "Sakaguchi S,"

Phrase: "Nakaoke R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "et al."
Processing 00000000.tx.178: PrP fragment 106-126 is toxic to cerebral endothelial cells expressing PrP(C). 

Phrase: "PrP fragment 106-126"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0032027:PRP [Disease or Syndrome]
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "is"

Phrase: "toxic to cerebral endothelial cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0600688:toxic [Injury or Poisoning]
   760   C1407029:Toxic [Qualitative Concept]

Phrase: "expressing"

Phrase: "PrP("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032027:PRP [Disease or Syndrome]

Phrase: "C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.179: Neuroreport. 

Phrase: "Neuroreport."
Processing 00000000.tx.180: 2000;11: 3931-3936.[Medline] [OrderarticleviaInfotrieve] Vinters HV, Wang ZZ, Secor DL. 

Phrase: "2000"

Phrase: ";11"

Phrase: ":"

Phrase: "3931-3936."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Vinters HV,"

Phrase: "Wang ZZ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347310:ZZ [Qualitative Concept]

Phrase: "Secor DL."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]
Processing 00000000.tx.181: Brain parenchymal and microvascular amyloid in Alzheimer's disease. 

Phrase: "Brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "parenchymal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0933845:Parenchyma [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "microvascular amyloid in Alzheimer's disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0002726:amyloid disease [Disease or Syndrome]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.182: Brain Pathol. 

Phrase: "Brain Pathol."
Processing 00000000.tx.183: 1996;6: 179-195.[Medline] [OrderarticleviaInfotrieve] Moody DM, Brown WR, Challa VR, et al. 

Phrase: "1996"

Phrase: ";6"

Phrase: ":"

Phrase: "179-195."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Moody DM,"

Phrase: "Brown WR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1420193:WR [Gene or Genome]
   861   C1425679:WR [Gene or Genome]
   861   C1862190:WR [Immunologic Factor]
   861   C3538902:WR [Gene or Genome]

Phrase: "Challa VR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3476815:VR [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.184: Cerebral microvascular alterations in aging, leukoaraiosis, and Alzheimer's disease. 

Phrase: "Cerebral microvascular alterations in aging,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0184524:Cerebral alteration [Finding]
   726   C1515926:Alteration [Idea or Concept]

Phrase: "leukoaraiosis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0521167:Leuko-araiosis [Finding]
  1000   C0948163:Leukoaraiosis [Pathologic Function]

Phrase: "and"

Phrase: "Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.185: Ann N Y Acad Sci. 

Phrase: "Ann N Y Acad Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.186: 1997;826: 103-16.:103-116.[Abstract] Mandybur TI, Bates SR. 

Phrase: "1997"

Phrase: ";826"

Phrase: ":"

Phrase: "103-16."

Phrase: ":"

Phrase: "103-116."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Mandybur TI,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040302:Ti [Element, Ion, or Isotope]
   861   C1553045:Ti [Quantitative Concept]
   861   C1704756:TI [Idea or Concept]

Phrase: "Bates"

Phrase: "SR."
Processing 00000000.tx.187: Fatal massive intracerebral hemorrhage complicating cerebral amyloid angiopathy. 

Phrase: "Fatal massive intracerebral hemorrhage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0333279:Massive haemorrhage [Pathologic Function]
   861   C2937358:Intracerebral Hemorrhage [Pathologic Function]
   812   C0019080:Haemorrhage [Pathologic Function]
   812   C0442111:Intracerebral [Spatial Concept]

Phrase: "complicating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231242:complicating [Functional Concept]
  1000   C1522701:Complicating [Functional Concept]

Phrase: "cerebral amyloid angiopathy."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0085220:Cerebral Amyloid Angiopathy [Disease or Syndrome]
   901   C2931784:Amyloid angiopathy [Disease or Syndrome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0042373:Angiopathy [Disease or Syndrome]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.188: Arch Neurol. 

Phrase: "Arch Neurol."
Processing 00000000.tx.189: 1978;35: 246-248.[Abstract] Blanc EM, Toborek M, Mark RJ, et al. 

Phrase: "1978"

Phrase: ";35"

Phrase: ":"

Phrase: "246-248."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Blanc EM,"

Phrase: "Toborek M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Mark RJ,"

Phrase: "et al."
Processing 00000000.tx.190: Amyloid beta-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells. 

Phrase: "Amyloid beta-peptide"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0078939:Amyloid beta-Peptide [Amino Acid, Peptide, or Protein]
  1000   C0611285:Amyloid Beta-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Amyloid
   901   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "cell monolayer albumin permeability,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0031164:Permeability [Natural Phenomenon or Process]
   741 E C0205326:Permeable [Functional Concept]

Phrase: "impairs"

Phrase: "glucose transport,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178666:glucose transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis in vascular endothelial cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C3156636:endothelial cell apoptosis [Cell Function]
   760   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.191: J Neurochem. 

Phrase: "J Neurochem."
Processing 00000000.tx.192: 1997;68: 1870-1881.[Medline] [OrderarticleviaInfotrieve] Kawai M, Kalaria RN, Cras P, et al. 

Phrase: "1997"

Phrase: ";68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ":"

Phrase: "1870-1881."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kawai M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kalaria RN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540639:RN [Gene or Genome]

Phrase: "Cras P,"

Phrase: "et al."
Processing 00000000.tx.193: Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease. 

Phrase: "Degeneration of vascular muscle cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0234958:DEGENERATION MUSCLE [Disease or Syndrome]
   797   C0333467:cells degeneration [Pathologic Function]
   797   C1281300:Vascular degeneration [Disease or Syndrome]
   760   C0011164:Degeneration [Pathologic Function]
   760   C1880269:Degeneration [Functional Concept]

Phrase: "in cerebral amyloid angiopathy"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0085220:Cerebral Amyloid Angiopathy [Disease or Syndrome]
   901   C2931784:Amyloid angiopathy [Disease or Syndrome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0042373:Angiopathy [Disease or Syndrome]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "of Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.194: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.195: 1993;623: 142-146.[CrossRef][Medline] [OrderarticleviaInfotrieve] Kalaria RN, Grahovac I. 

Phrase: "1993"

Phrase: ";623"

Phrase: ":"

Phrase: "142-146."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kalaria RN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540639:RN [Gene or Genome]

Phrase: "Grahovac I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.196: Serum amyloid P immunoreactivity in hippocampal tangles, plaques and vessels: implications for leakage across the blood-brain barrier in Alzheimer's disease. 

Phrase: "Serum amyloid P immunoreactivity in hippocampal tangles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0597879:immunoreactivity [Molecular Function]

Phrase: "plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "and"

Phrase: "vessels"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0005847:Vessels [Body Part, Organ, or Organ Component]
   966 E C1511228:Vessel [Tissue]
   928 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "implications for leakage"

Phrase: "across the blood-brain barrier"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
  1000   C0005854:Blood-Brain Barrier [Body Part, Organ, or Organ Component]
  1000   C1305865:Blood-brain barrier [Organ or Tissue Function]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0229664:Blood [Body Substance]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C1706912:BARRIER [Medical Device]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.197: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.198: 1990;516: 349-353.[CrossRef][Medline] [OrderarticleviaInfotrieve] Kalaria RN, Hedera P. 

Phrase: "1990"

Phrase: ";516"

Phrase: ":"

Phrase: "349-353."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kalaria RN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540639:RN [Gene or Genome]

Phrase: "Hedera P."
Processing 00000000.tx.199: Differential degeneration of the cerebral microvasculature in Alzheimer's disease. 

Phrase: "Differential degeneration of the cerebral microvasculature"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0154671:Cerebral degeneration [Disease or Syndrome]
   753   C0011164:Degeneration [Pathologic Function]
   753   C1880269:Degeneration [Functional Concept]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.200: Neuroreport. 

Phrase: "Neuroreport."
Processing 00000000.tx.201: 1995;6: 477-480.[Medline] [OrderarticleviaInfotrieve] Castillo MJ, Scheen AJ, Lefebvre PJ. 

Phrase: "1995"

Phrase: ";6"

Phrase: ":"

Phrase: "477-480."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Castillo MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Scheen AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Lefebvre PJ."
Processing 00000000.tx.202: Amylin/islet amyloid polypeptide: biochemistry, physiology, patho-physiology. 

Phrase: "Amylin/islet amyloid polypeptide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
   923   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: ":"

Phrase: "biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "physiology,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031842:Physiology [Biomedical Occupation or Discipline]
  1000   C0031843:physiology [Physiologic Function]
   928 E C0205463:Physiologic [Functional Concept]

Phrase: "patho-physiology."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0031842:Physiology [Biomedical Occupation or Discipline]
   861   C0031843:physiology [Physiologic Function]
   789 E C0205463:Physiologic [Functional Concept]
Processing 00000000.tx.203: Diabetes Metab. 

Phrase: "Diabetes Metab."
Processing 00000000.tx.204: 1995;21: 3-25. 

Phrase: "1995"

Phrase: ";21"

Phrase: ":"

Phrase: "3-25."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]
Processing 00000000.tx.205: Kranenburg O, Bouma B, Kroon-Batenburg LM, et al. 

Phrase: "Kranenburg O,"

Phrase: "Bouma B,"

Phrase: "Kroon-Batenburg LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1261082:LM [Body Part, Organ, or Organ Component]
   827   C1551056:lm [Quantitative Concept]
   827   C2981682:LM [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.206: Tissue-type plasminogen activator is a multiligand cross-beta structure receptor. 

Phrase: "Tissue-type plasminogen activator"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0032143:Tissue-Type Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
           Tissue Plasminogen Activator
   923   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   861   C0019633:tissue type [Laboratory Procedure]
   861   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C2713035:Tissue type [Tissue]
   812   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0040300:Tissue [Tissue]
   812   C0332307:Type [Qualitative Concept]
   812   C1367553:PLASMINOGEN [Gene or Genome]
   812   C1547052:*Type [Quantitative Concept]
   812   C1547928:Tissue [Intellectual Product]

Phrase: "is"

Phrase: "a multiligand cross-beta structure receptor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.207: Curr Biol. 

Phrase: "Curr Biol."
Processing 00000000.tx.208: 2002;12: 1833-1839.[CrossRef][Medline] [OrderarticleviaInfotrieve] Deininger MH, Fimmen BA, Thal DR, et al. 

Phrase: "2002"

Phrase: ";12"

Phrase: ":"

Phrase: "1833-1839."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Deininger MH,"

Phrase: "Fimmen BA,"

Phrase: "Thal DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "et al."
Processing 00000000.tx.209: Aberrant neuronal and paracellular deposition of endostatin in brains of patients with Alzheimer's disease. 

Phrase: "Aberrant neuronal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0521390:Neuronal [Immunologic Factor]
   789 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "paracellular deposition of endostatin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0333562:Deposition [Functional Concept]

Phrase: "in brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.210: J Neurosci. 

Phrase: "J Neurosci."
Processing 00000000.tx.211: 2002;22: 10621-10626.[Abstract/Free FullText] Machovich R, Owen WG. 

Phrase: "2002"

Phrase: ";22"

Phrase: ":"

Phrase: "10621-10626."

Phrase: "[Abstract/Free FullText"

Phrase: "] Machovich R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Owen WG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043092:WG [Disease or Syndrome]
Processing 00000000.tx.212: Denatured proteins as cofactors for plasminogen activation. 

Phrase: "Denatured proteins as cofactors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "for plasminogen activation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1622667:plasminogen activation [Molecular Function]
   861   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1367553:PLASMINOGEN [Gene or Genome]
   861   C1879547:Activation [Activity]
Processing 00000000.tx.213: Arch Biochem Biophys. 

Phrase: "Arch Biochem Biophys."
Processing 00000000.tx.214: 1997;344: 343-349.[CrossRef][Medline] [OrderarticleviaInfotrieve] Kingston IB, Castro MJ, Anderson S. 

Phrase: "1997"

Phrase: ";344"

Phrase: ":"

Phrase: "343-349."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kingston IB,"

Phrase: "Castro MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Anderson S."
Processing 00000000.tx.215: In vitro stimulation of tissue-type plasminogen activator by Alzheimer amyloid beta-peptide analogues. 

Phrase: "In vitro stimulation of tissue-type plasminogen activator"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   744   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "by Alzheimer amyloid beta-peptide analogues."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C0243071:Analogue [Chemical Viewed Structurally]
   717   C0078939:Amyloid beta-Peptide [Amino Acid, Peptide, or Protein]
   717   C0611285:Amyloid Beta-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.216: Nat Med. 

Phrase: "Nat Med."
Processing 00000000.tx.217: 1995;1: 138-142.[Medline] [OrderarticleviaInfotrieve] Ellis V, Daniels M, Misra R, Brown DR. 

Phrase: "1995"

Phrase: ";1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "138-142."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ellis V,"

Phrase: "Daniels M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Misra R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Brown DR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]
Processing 00000000.tx.218: Plasminogen activation is stimulated by prion protein and regulated in a copper-dependent manner. 

Phrase: "Plasminogen activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1622667:plasminogen activation [Molecular Function]
   861   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1367553:PLASMINOGEN [Gene or Genome]
   861   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "stimulated by prion protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   833   C1418941:PRION PROTEIN [Gene or Genome]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "regulated in a copper-dependent manner."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0009968:Copper [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C2347872:Copper+ [Element, Ion, or Isotope]
   753   C2348263:Copper [Element, Ion, or Isotope]
   753   C3244310:dependent [Functional Concept]
Processing 00000000.tx.219: Biochemistry. 

Phrase: "Biochemistry."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]
Processing 00000000.tx.220: 2002;41: 6891-6896.[CrossRef][Medline] [OrderarticleviaInfotrieve] Huang YY, Bach ME, Lipp HP, et al. 

Phrase: "2002"

Phrase: ";41"

Phrase: ":"

Phrase: "6891-6896."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Huang YY,"

Phrase: "Bach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1825831:BACH [Gene or Genome]

Phrase: "ME,"

Phrase: "Lipp HP,"

Phrase: "et al."
Processing 00000000.tx.221: Mice lacking the gene encoding tissue-type plasminogen activator show a selective interference with late-phase long-term potentiation in both Schaffer collateral and mossy fiber pathways. 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "the gene encoding tissue-type plasminogen activator"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   901   C0032143:Tissue-Type Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
           Tissue Plasminogen Activator
   867   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   858   C0314611:Gene type [Genetic Function]
   827   C0019633:tissue type [Laboratory Procedure]
   827   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C2713035:Tissue type [Tissue]
   799   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   799   C0040300:Tissue [Tissue]
   799   C0332307:Type [Qualitative Concept]
   799   C1367553:PLASMINOGEN [Gene or Genome]
   799   C1547052:*Type [Quantitative Concept]
   799   C1547928:Tissue [Intellectual Product]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a selective interference with late-phase long-term potentiation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0521102:Interference [Qualitative Concept]

Phrase: "in both Schaffer collateral"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3544403:Schaffer collateral [Cell Component]
   861   C1275670:Collateral [Body Part, Organ, or Organ Component]
   861   C1948058:Collateral [Spatial Concept]

Phrase: "and"

Phrase: "mossy fiber pathways."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]
   734   C0596975:mossy fiber [Cell Component]
Processing 00000000.tx.222: Proc Natl Acad Sci U S A. 

Phrase: "Proc Natl Acad Sci U S A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   845   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.223: 1996;93: 8699-8704.[Abstract/Free FullText] Seeds NW, Basham ME, Haffke SP. 

Phrase: "1996"

Phrase: ";93"

Phrase: ":"

Phrase: "8699-8704."

Phrase: "[Abstract/Free FullText"

Phrase: "] Seeds NW,"

Phrase: "Basham"

Phrase: "ME,"

Phrase: "Haffke SP."
Processing 00000000.tx.224: Neuronal migration is retarded in mice lacking the tissue plasminogen activator gene. 

Phrase: "Neuronal migration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1326504:neuronal migration [Cell Function]
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "is"

Phrase: "retarded in mice"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   790   C0521111:Retarded [Qualitative Concept]
   718 E C0311403:Inhibited [Qualitative Concept]
   718 E C3463820:Inhibiting [Activity]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "the tissue plasminogen activator gene."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C1367553:Plasminogen Gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   756   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   756   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
Processing 00000000.tx.225: Proc Natl Acad Sci U S A. 

Phrase: "Proc Natl Acad Sci U S A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   845   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.226: 1999;96: 14118-14123.[Abstract/Free FullText] Tsirka SE. 

Phrase: "1999"

Phrase: ";96"

Phrase: ":"

Phrase: "14118-14123."

Phrase: "[Abstract/Free FullText"

Phrase: "] Tsirka SE."
Processing 00000000.tx.227: Tissue plasminogen activator as a modulator of neuronal survival and function. 

Phrase: "Tissue plasminogen activator as a modulator of neuronal survival"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   790   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   764   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   762   C0040297:Tissue Survival [Organ or Tissue Function]
   742   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0040300:Tissue [Tissue]
   742   C1367553:PLASMINOGEN [Gene or Genome]
   742   C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.228: Biochem Soc Trans. 

Phrase: "Biochem Soc Trans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2826298:TRANS [Idea or Concept]
Processing 00000000.tx.229: 2002;30: 222-225.[CrossRef][Medline] [OrderarticleviaInfotrieve] Chen ZL, Strickland S. 

Phrase: "2002"

Phrase: ";30"

Phrase: ":"

Phrase: "222-225."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Chen ZL,"

Phrase: "Strickland S."
Processing 00000000.tx.230: Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. 

Phrase: "Neuronal death in the hippocampus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C2754100:neuron death [Cell Function]
   760   C0011065:Death [Organism Function]
   760   C1306577:Death, NOS [Finding]

Phrase: "is"

Phrase: "promoted by plasmin-catalyzed degradation of laminin."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0016016:Plasmin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]
   714   C0033414:Promote [Activity]
Processing 00000000.tx.231: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.232: 1997;91: 917-925.[Medline] [OrderarticleviaInfotrieve] Tsirka SE, Gualandris A, Amaral DG, Strickland S. 

Phrase: "1997"

Phrase: ";91"

Phrase: ":"

Phrase: "917-925."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Tsirka SE,"

Phrase: "Gualandris A,"

Phrase: "Amaral DG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1275573:dg [Quantitative Concept]

Phrase: "Strickland S."
Processing 00000000.tx.233: Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. 

Phrase: "Excitotoxin-induced neuronal degeneration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   825   C0027746:Neuron Degeneration [Cell or Molecular Dysfunction]
   812   C0011164:Degeneration [Pathologic Function]
   812   C1880269:Degeneration [Functional Concept]

Phrase: "and"

Phrase: "seizure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036572:Seizure [Sign or Symptom]
  1000   C1959629:Seizure [Finding]

Phrase: "are"

Phrase: "mediated by tissue plasminogen activator."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   862   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   806   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0040300:Tissue [Tissue]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C1367553:PLASMINOGEN [Gene or Genome]
   760   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.234: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.235: 1995;377: 340-344.[CrossRef][Medline] [OrderarticleviaInfotrieve] Wang YF, Tsirka SE, Strickland S, et al. 

Phrase: "1995"

Phrase: ";377"

Phrase: ":"

Phrase: "340-344."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wang YF,"

Phrase: "Tsirka SE,"

Phrase: "Strickland S,"

Phrase: "et al."
Processing 00000000.tx.236: Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. 

Phrase: "Tissue plasminogen activator"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   901   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0040300:Tissue [Tissue]
   827   C1367553:PLASMINOGEN [Gene or Genome]
   827   C1547928:Tissue [Intellectual Product]

Phrase: "(tPA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C1367553:PLASMINOGEN [Gene or Genome]

Phrase: ")"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "neuronal damage after focal cerebral ischemia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0270611:cerebral damage [Injury or Poisoning]
   753   C0010957:Damage [Injury or Poisoning]
   753   C1883709:Damage [Functional Concept]

Phrase: "in wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "tPA-deficient mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
Processing 00000000.tx.237: Nat Med. 

Phrase: "Nat Med."
Processing 00000000.tx.238: 1998;4: 228-231.[Medline] [OrderarticleviaInfotrieve] Isik FF, Gibran NS, Jang YC, et al. 

Phrase: "1998"

Phrase: ";4"

Phrase: ":"

Phrase: "228-231."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Isik FF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539653:FF [Idea or Concept]

Phrase: "Gibran NS,"

Phrase: "Jang YC,"

Phrase: "et al."
Processing 00000000.tx.239: Vitronectin decreases microvascular endothelial cell apoptosis. 

Phrase: "Vitronectin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0055023:Vitronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336937:VITRONECTIN [Gene or Genome]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "microvascular endothelial cell apoptosis."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   923   C3156636:endothelial cell apoptosis [Cell Function]
   812   C0162638:Apoptosis [Cell Function]
   741 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.240: J Cell Physiol. 

Phrase: "J Cell Physiol."
Processing 00000000.tx.241: 1998;175: 149-155.[CrossRef][Medline] [OrderarticleviaInfotrieve] Ge M, Tang G, Ryan TJ, Malik AB. 

Phrase: "1998"

Phrase: ";175"

Phrase: ":"

Phrase: "149-155."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ge M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Tang G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Ryan TJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]

Phrase: "Malik AB."
Processing 00000000.tx.242: Fibrinogen degradation product fragment D induces endothelial cell detachment by activation of cell-mediated fibrinolysis. 

Phrase: "Fibrinogen degradation product fragment D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   911   C0060335:fragment D, fibrinogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0163275:Fibrinogen degradation product [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "endothelial cell detachment by activation of cell-mediated fibrinolysis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0541879:detachment [Mental Process]
   742   C0595950:Detachment [Pathologic Function]
Processing 00000000.tx.243: J Clin Invest. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest."
Processing 00000000.tx.244: 1992;90: 2508-2516.[Medline] [OrderarticleviaInfotrieve] Reinartz J, Schafer B, Batrla R, et al. 

Phrase: "1992"

Phrase: ";90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: ":"

Phrase: "2508-2516."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Reinartz J,"

Phrase: "Schafer B,"

Phrase: "Batrla R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "et al."
Processing 00000000.tx.245: Plasmin abrogates alpha v beta 5-mediated adhesion of a human keratinocyte cell line (HaCaT) to vitronectin. 

Phrase: "Plasmin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016016:Plasmin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "abrogates"

Phrase: "alpha v beta 5-mediated adhesion of a human keratinocyte cell line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   751   C0007577:Cell Adhesion [Cell Function]
   736   C0001511:Adhesion [Pathologic Function]
   736   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "(HaCaT"

Phrase: ")"

Phrase: "to vitronectin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0055023:Vitronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336937:VITRONECTIN [Gene or Genome]
Processing 00000000.tx.246: Exp Cell Res. 

Phrase: "Exp Cell Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347379:RES [Finding]
Processing 00000000.tx.247: 1995;220: 274-282.[CrossRef][Medline] [OrderarticleviaInfotrieve] Sugimura M, Kobayashi H, Terao T. 

Phrase: "1995"

Phrase: ";220"

Phrase: ":"

Phrase: "274-282."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sugimura M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kobayashi H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Terao T."
Processing 00000000.tx.248: Plasmin modulators, aprotinin and anti-catalytic plasmin antibody, efficiently inhibit destruction of bovine vascular endothelial cells by choriocarcinoma cells. 

Phrase: "Plasmin modulators,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709060:Modulator [Manufactured Object]

Phrase: "aprotinin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "anti-catalytic plasmin antibody,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0162594:Antibody, Catalytic [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "efficiently"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "destruction of bovine vascular endothelial cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1261381:Destruction [Therapeutic or Preventive Procedure]
   753   C1948029:Destruction [Activity]

Phrase: "by choriocarcinoma cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.249: Gynecol Oncol. 

Phrase: "Gynecol Oncol."
Processing 00000000.tx.250: 1994;52: 337-346.[CrossRef][Medline] [OrderarticleviaInfotrieve] Davis GE, Pintar Allen KA, Salazar R, Maxwell SA. 

Phrase: "1994"

Phrase: ";52"

Phrase: ":"

Phrase: "337-346."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Davis GE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538705:GE [Gene or Genome]

Phrase: "Pintar Allen KA,"

Phrase: "Salazar R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Maxwell SA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]
Processing 00000000.tx.251: Matrix metalloproteinase-1 and -9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices. 

Phrase: "Matrix metalloproteinase-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0127082:Matrix Metalloproteinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417199:MATRIX METALLOPROTEINASE 1 [Gene or Genome]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "and -"

Phrase: "9 activation by plasmin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "regulates"

Phrase: "a novel endothelial cell-mediated mechanism of collagen gel contraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0441712:Mechanism [Functional Concept]
   739   C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "capillary tube regression in three-dimensional collagen matrices."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0684320:Regression [Pathologic Function]
   744   C0684321:Regression [Mental Process]
Processing 00000000.tx.252: J Cell Sci. 

Phrase: "J Cell Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.253: 2001;114: 917-930.[Abstract/Free FullText] Rossignol P, Ho-Tin-Noe B, Vranckx R, et al. 

Phrase: "2001"

Phrase: ";114"

Phrase: ":"

Phrase: "917-930."

Phrase: "[Abstract/Free FullText"

Phrase: "] Rossignol P,"

Phrase: "Ho-Tin-Noe B,"

Phrase: "Vranckx R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "et al."
Processing 00000000.tx.254: Protease nexin-1 inhibits plasminogen activation-induced apoptosis of adherent cells. 

Phrase: "Protease nexin-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C2936358:Nexin, Protease [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0030190:Nexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0132332:nexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418552:nexin [Gene or Genome]
   827   C1947941:Protease [Enzyme]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "plasminogen activation-induced apoptosis of adherent cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   800   C3266896:activation of apoptosis [Cell Function]
   748   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.255: J Biol Chem. 

Phrase: "J Biol Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.256: 2004;279: 10346-10356.[Abstract/Free FullText] Meilhac O, Ho-Tin-Noe B, Houard X, et al. 

Phrase: "2004"

Phrase: ";279"

Phrase: ":"

Phrase: "10346-10356."

Phrase: "[Abstract/Free FullText"

Phrase: "] Meilhac O,"

Phrase: "Ho-Tin-Noe B,"

Phrase: "Houard X,"

Phrase: "et al."
Processing 00000000.tx.257: Pericellular plasmin induces smooth muscle cell anoikis. 

Phrase: "Pericellular plasmin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016016:Plasmin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "smooth muscle cell anoikis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0872097:Anoikis [Cell Function]
   756   C1135918:Smooth muscle cell [Cell]
Processing 00000000.tx.258: FASEB J. 

Phrase: "FASEB J."
Processing 00000000.tx.259: 2003;17: 1301-1303.[Abstract/Free FullText] Huttunen HJ, Fages C, Kuja-Panula J, et al. 

Phrase: "2003"

Phrase: ";17"

Phrase: ":"

Phrase: "1301-1303."

Phrase: "[Abstract/Free FullText"

Phrase: "] Huttunen HJ,"

Phrase: "Fages C,"

Phrase: "Kuja-Panula J,"

Phrase: "et al."
Processing 00000000.tx.260: Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. 

Phrase: "Receptor for advanced glycation end products-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   716   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "COOH-terminal motif of amphoterin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514562:Motif [Amino Acid Sequence]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "invasive migration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "and"

Phrase: "metastasis."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0027627:Metastasis [Neoplastic Process]
  1000   C2939420:metastasis [Neoplastic Process]
   928 E C0036525:Metastatic [Functional Concept]
   928 E C1522484:metastatic [Quantitative Concept]
Processing 00000000.tx.261: Cancer Res. 

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.262: 2002;62: 4805-4811.[Abstract/Free FullText] Dawson DW, Pearce SF, Zhong R, et al. 

Phrase: "2002"

Phrase: ";62"

Phrase: ":"

Phrase: "4805-4811."

Phrase: "[Abstract/Free FullText"

Phrase: "] Dawson DW,"

Phrase: "Pearce SF,"

Phrase: "Zhong R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "et al."
Processing 00000000.tx.263: CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells. 

Phrase: "CD36"

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the In vitro inhibitory effects of thrombospondin-1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "on endothelial cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.264: J Cell Biol. 

Phrase: "J Cell Biol."
Processing 00000000.tx.265: 1997;138: 707-717.[Free FullText] Suo Z, Fang C, Crawford F, Mullan M. 

Phrase: "1997"

Phrase: ";138"

Phrase: ":"

Phrase: "707-717."

Phrase: "[Free FullText"

Phrase: "] Suo Z,"

Phrase: "Fang C,"

Phrase: "Crawford F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Mullan M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.266: Superoxide free radical and intracellular calcium mediate A beta(1-42) induced endothelial toxicity. 

Phrase: "Superoxide free radical"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   913   C0038836:Superoxide Radical [Element, Ion, or Isotope]
   901   C0016693:Free radical [Biologically Active Substance,Chemical Viewed Structurally]
   827   C0302912:Radical [Chemical Viewed Structurally]
   827   C0332296:free [Functional Concept]
   827   C0439807:Radical [Qualitative Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]

Phrase: "and"

Phrase: "intracellular calcium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0006726:Calcium [Inorganic Chemical]
   861   C2936886:Calcium [Pharmacologic Substance]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "A beta"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420510:A-BETA [Gene or Genome]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "endothelial toxicity."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]
Processing 00000000.tx.267: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.268: 1997;762: 144-152.[CrossRef][Medline] [OrderarticleviaInfotrieve] Hase M, Araki S, Hayashi H. 

Phrase: "1997"

Phrase: ";762"

Phrase: ":"

Phrase: "144-152."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hase M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Araki S,"

Phrase: "Hayashi H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.269: Fragments of amyloid beta induce apoptosis in vascular endothelial cells. 

Phrase: "Fragments of amyloid beta"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0332255:fragments [Functional Concept]
   770   C0486805:Fragments [Body Substance]
   737 E C1708096:Fragment [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis in vascular endothelial cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C3156636:endothelial cell apoptosis [Cell Function]
   760   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.270: Endothelium. 

Phrase: "Endothelium."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014257:Endothelium [Tissue]
Processing 00000000.tx.271: 1997;5: 221-229.[Medline] [OrderarticleviaInfotrieve] Stepanichev MY, Zdobnova IM, Yakovlev AA, et al. 

Phrase: "1997"

Phrase: ";5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ":"

Phrase: "221-229."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Stepanichev"

Phrase: "MY,"

Phrase: "Zdobnova IM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539078:IM [Idea or Concept]

Phrase: "Yakovlev AA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1235746:Aa [Plant]
   861   C1882141:aa [Qualitative Concept]

Phrase: "et al."
Processing 00000000.tx.272: Effects of tumor necrosis factor-alpha central administration on hippocampal damage in rat induced by amyloid beta-peptide (25-35). 

Phrase: "Effects of tumor necrosis factor-alpha central administration"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "on hippocampal damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010957:Damage [Injury or Poisoning]
   861   C1883709:Damage [Functional Concept]

Phrase: "in rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: "induced by amyloid beta-peptide"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   862   C0078939:Amyloid beta-Peptide [Amino Acid, Peptide, or Protein]
   862   C0611285:Amyloid Beta-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Amyloid
   806   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   797 E C2825879:Amyloid, Beta [Laboratory Procedure]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0205263:Induced [Functional Concept]
   760   C0330390:Beta [Plant]
   760   C0439096:Beta [Intellectual Product]
   760   C2004068:Beta [Qualitative Concept]

Phrase: "(25-35"

Phrase: ")."
Processing 00000000.tx.273: J Neurosci Res. 

Phrase: "J Neurosci Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347379:RES [Finding]
Processing 00000000.tx.274: 2003;71: 110-120.[CrossRef][Medline] [OrderarticleviaInfotrieve] Gasic-Milenkovic J, Dukic-Stefanovic S, Deuther-Conrad W, et al. beta-Amyloid peptide potentiates inflammatory responses induced by lipopolysaccharide, interferon-gamma and "advanced glycation endproducts" in a murine microglia cell line. 

Phrase: "2003"

Phrase: ";71"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: ":"

Phrase: "110-120."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Gasic-Milenkovic J,"

Phrase: "Dukic-Stefanovic S,"

Phrase: "Deuther-Conrad W,"

Phrase: "et al. beta-Amyloid peptide"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   840   C2825879:Amyloid, Beta [Laboratory Procedure]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   804   C0330390:Beta [Plant]
   804   C0439096:Beta [Intellectual Product]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C2004068:Beta [Qualitative Concept]

Phrase: "potentiates"

Phrase: "inflammatory responses"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1155266:inflammatory responses [Pathologic Function]
   861   C0871261:responses [Organism Attribute]
   827 E C1704632:Response [Finding]
   827 E C1706817:Response [Intellectual Product]
   827 E C2911692:Response [Mental Process]

Phrase: "induced by lipopolysaccharide,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0023810:Lipopolysaccharide [Lipid]
   790   C0205263:Induced [Functional Concept]

Phrase: "interferon-gamma"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0021740:Interferon Gamma [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0021745:Interferon-gamma [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C1149405:interferon-gamma [Molecular Function]
  1000   C2757040:Interferon gamma [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0017011:Gamma [Natural Phenomenon or Process]
   861   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C1552644:Gamma [Intellectual Product]
   861   C2349976:Gamma [Quantitative Concept]

Phrase: "and """

Phrase: "advanced glycation endproducts"""
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0205179:Advanced [Qualitative Concept]
   827   C0598528:glycation [Phenomenon or Process]
   793 E C0725066:Advance [Medical Device]

Phrase: "in a murine microglia cell line."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0007600:Cell Line [Cell]
   825   C0206116:Microglial cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.275: Eur J Neurosci. 

Phrase: "Eur J Neurosci."
Processing 00000000.tx.276: 2003;17: 813-821.[CrossRef][Medline] [OrderarticleviaInfotrieve] Rochet JC, Lansbury PT Jr. 

Phrase: "2003"

Phrase: ";17"

Phrase: ":"

Phrase: "813-821."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Rochet JC,"

Phrase: "Lansbury PT Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.277: Amyloid fibrillogenesis: themes and variations. 

Phrase: "Amyloid fibrillogenesis"

Phrase: ":"

Phrase: "themes"

Phrase: "and"

Phrase: "variations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:variations [Qualitative Concept]
Processing 00000000.tx.278: Curr Opin Struct Biol. 

Phrase: "Curr Opin Struct Biol."
Processing 00000000.tx.279: 2000;10: 60-68.[CrossRef][Medline] [OrderarticleviaInfotrieve] Volpert OV, Lawler J, Bouck NP. 

Phrase: "2000"

Phrase: ";10"

Phrase: ":"

Phrase: "60-68."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450387:68 [Intellectual Product]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Volpert OV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0445574:ov [Intellectual Product]

Phrase: "Lawler J,"

Phrase: "Bouck NP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706141:NP [Gene or Genome]
Processing 00000000.tx.280: A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1. 

Phrase: "A human fibrosarcoma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016057:Fibrosarcoma [Neoplastic Process]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "systemic angiogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0302600:Angiogenesis [Organ or Tissue Function]
   861   C1519670:angiogenesis [Neoplastic Process]

Phrase: "and"

Phrase: "the growth of experimental metastases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2911660:Growth [Activity]

Phrase: "via thrombospondin-1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0147139:Thrombospondin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336626:THROMBOSPONDIN I [Gene or Genome]
   861   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.281: Proc Natl Acad Sci U S A. 

Phrase: "Proc Natl Acad Sci U S A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   845   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.282: 1998;95: 6343-6348.[Abstract/Free FullText] Silverstein RL, Nachman RL, Leung LL, Harpel PC. 

Phrase: "1998"

Phrase: ";95"

Phrase: ":"

Phrase: "6343-6348."

Phrase: "[Abstract/Free FullText"

Phrase: "] Silverstein RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "Nachman RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "Leung LL,"

Phrase: "Harpel PC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]
Processing 00000000.tx.283: Activation of immobilized plasminogen by tissue activator. 

Phrase: "Activation of immobilized plasminogen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1622667:plasminogen activation [Molecular Function]
   770   C1879547:Activation [Activity]

Phrase: "by tissue activator."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.284: Multimolecular complex formation. 

Phrase: "Multimolecular complex formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
Processing 00000000.tx.285: J Biol Chem. 

Phrase: "J Biol Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.286: 1985;260: 10346-10352.[Abstract/Free FullText] Silverstein RL, Leung LL, Harpel PC, Nachman RL. 

Phrase: "1985"

Phrase: ";260"

Phrase: ":"

Phrase: "10346-10352."

Phrase: "[Abstract/Free FullText"

Phrase: "] Silverstein RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "Leung LL,"

Phrase: "Harpel PC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: "Nachman RL."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]
Processing 00000000.tx.287: Complex formation of platelet thrombospondin with plasminogen. 

Phrase: "Complex formation of platelet thrombospondin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1159962:platelet formation [Cell Function]
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "with plasminogen."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1367553:PLASMINOGEN [Gene or Genome]
Processing 00000000.tx.288: Modulation of activation by tissue activator. 

Phrase: "Modulation of activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0443264:Modulation [Spatial Concept]

Phrase: "by tissue activator."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.289: J Clin Invest. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest."
Processing 00000000.tx.290: 1984;74: 1625-1633.[Medline] [OrderarticleviaInfotrieve] Silverstein RL, Harpel PC, Nachman RL. 

Phrase: "1984"

Phrase: ";74"

Phrase: ":"

Phrase: "1625-1633."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Silverstein RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "Harpel PC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: "Nachman RL."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]
Processing 00000000.tx.291: Tissue plasminogen activator and urokinase enhance the binding of plasminogen to thrombospondin. 

Phrase: "Tissue plasminogen activator"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   901   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0040300:Tissue [Tissue]
   827   C1367553:PLASMINOGEN [Gene or Genome]
   827   C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "urokinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042071:Urokinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1335224:UROKINASE [Gene or Genome]
  1000   C1522670:Urokinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the binding of plasminogen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "to thrombospondin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.292: J Biol Chem. 

Phrase: "J Biol Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.293: 1986;261: 9959-9965.[Abstract/Free FullText] Machovich R, Komorowicz E, Kolev K, Owen WG. 

Phrase: "1986"

Phrase: ";261"

Phrase: ":"

Phrase: "9959-9965."

Phrase: "[Abstract/Free FullText"

Phrase: "] Machovich R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Komorowicz E,"

Phrase: "Kolev K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Owen WG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043092:WG [Disease or Syndrome]
Processing 00000000.tx.294: Facilitation of plasminogen activation by denatured prothrombin. 

Phrase: "Facilitation of plasminogen activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "by denatured prothrombin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033706:Prothrombin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C2828369:Prothrombin [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.295: Thromb Res. 

Phrase: "Thromb Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.296: 1999;94: 389-394.[CrossRef][Medline] [OrderarticleviaInfotrieve] Griffioen AW, van der Schaft DW, Barendsz-Janson AF, et al. 

Phrase: "1999"

Phrase: ";94"

Phrase: ":"

Phrase: "389-394."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Griffioen AW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282379:AW [Geographic Area]
   861   C0332281:AW [Qualitative Concept]

Phrase: "van der Schaft DW,"

Phrase: "Barendsz-Janson AF,"

Phrase: "et al."
Processing 00000000.tx.297: Anginex, a designed peptide that inhibits angiogenesis. 

Phrase: "Anginex,"

Phrase: "a designed peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "that"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "angiogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0302600:Angiogenesis [Organ or Tissue Function]
  1000   C1519670:angiogenesis [Neoplastic Process]
Processing 00000000.tx.298: Biochem J. 

Phrase: "Biochem J."
Processing 00000000.tx.299: 2001;354: 233-242.[CrossRef][Medline] [OrderarticleviaInfotrieve] Zou Z, Anisowicz A, Hendrix MJ, et al. 

Phrase: "2001"

Phrase: ";354"

Phrase: ":"

Phrase: "233-242."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Zou Z,"

Phrase: "Anisowicz A,"

Phrase: "Hendrix MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "et al."
Processing 00000000.tx.300: Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. 

Phrase: "Maspin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0250870:maspin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C0919445:MASPIN [Gene or Genome]

Phrase: "a serpin with tumor-suppressing activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1152590:serpin activity [Molecular Function]
   783   C1152593:serpin activity [Molecular Function]
   753   C0036764:Serpin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "in human mammary epithelial cells."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   902   C0427861:Human cells [Laboratory or Test Result]
   861   C0014597:Epithelial Cells [Cell]
   861   C1273342:Epithelial Cells [Laboratory Procedure]
   812   C0006141:Mammary [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0086418:Human [Human]
   812   C0221908:Epithelial [Qualitative Concept]
   812   C0929301:Mammary [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.301: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.302: 1994;263: 526-529.[Medline] [OrderarticleviaInfotrieve] Sheng S, Truong B, Fredrickson D, et al. 

Phrase: "1994"

Phrase: ";263"

Phrase: ":"

Phrase: "526-529."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sheng S,"

Phrase: "Truong B,"

Phrase: "Fredrickson D,"

Phrase: "et al."
Processing 00000000.tx.303: Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin. 

Phrase: "Tissue-type plasminogen activator"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0032143:Tissue-Type Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
           Tissue Plasminogen Activator
   923   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   861   C0019633:tissue type [Laboratory Procedure]
   861   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C2713035:Tissue type [Tissue]
   812   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0040300:Tissue [Tissue]
   812   C0332307:Type [Qualitative Concept]
   812   C1367553:PLASMINOGEN [Gene or Genome]
   812   C1547052:*Type [Quantitative Concept]
   812   C1547928:Tissue [Intellectual Product]

Phrase: "is"

Phrase: "a target of the tumor suppressor gene maspin."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1332838:Target Gene [Gene or Genome]
   744   C1521840:Target [Functional Concept]
   744   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.304: Proc Natl Acad Sci U S A. 

Phrase: "Proc Natl Acad Sci U S A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   845   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.305: 1998;95: 499-504.[Abstract/Free FullText] Juarez JC, Guan X, Shipulina NV, et al. 

Phrase: "1998"

Phrase: ";95"

Phrase: ":"

Phrase: "499-504."

Phrase: "[Abstract/Free FullText"

Phrase: "] Juarez JC,"

Phrase: "Guan X,"

Phrase: "Shipulina NV,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027951:NV [Geographic Area]
   861   C3540591:NV [Idea or Concept]

Phrase: "et al."
Processing 00000000.tx.306: Histidineproline-rich glycoprotein has potent antiangiogenic activity mediated through the histidine-proline-rich domain. 

Phrase: "Histidineproline-rich glycoprotein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017968:Glycoprotein [Amino Acid, Peptide, or Protein,Carbohydrate]

Phrase: "has"

Phrase: "potent antiangiogenic activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "mediated through the histidine-proline-rich domain."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C1514490:Proline-Rich Domain [Amino Acid Sequence]
   748   C0019602:Histidine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0033382:Proline [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   748   C0699759:Rich [Qualitative Concept]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.307: Cancer Res. 

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.308: 2002;62: 5344-5350.[Abstract/Free FullText] Borza DB, Morgan WT. 

Phrase: "2002"

Phrase: ";62"

Phrase: ":"

Phrase: "5344-5350."

Phrase: "[Abstract/Free FullText"

Phrase: "] Borza DB,"

Phrase: "Morgan WT."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2700323:WT [Fish]
Processing 00000000.tx.309: Acceleration of plasminogen activation by tissue plasminogen activator on surface-bound histidine-proline-rich glycoprotein. 

Phrase: "Acceleration of plasminogen activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0000894:Acceleration [Phenomenon or Process]

Phrase: "by tissue plasminogen activator"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   901   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0040300:Tissue [Tissue]
   827   C1367553:PLASMINOGEN [Gene or Genome]
   827   C1547928:Tissue [Intellectual Product]

Phrase: "on surface-bound histidine-proline-rich glycoprotein."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C1455836:histidine-proline rich glycoprotein [Gene or Genome]
           HISTIDINE-RICH GLYCOPROTEIN
   901   C1616557:histidine-proline-rich glycoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   895   C0025248:Surface Glycoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   867   C0243518:histidine-rich glycoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0017968:Glycoprotein [Amino Acid, Peptide, or Protein,Carbohydrate]
   799   C0019602:Histidine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   799   C0033382:Proline [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0699759:Rich [Qualitative Concept]
Processing 00000000.tx.310: J Biol Chem. 

Phrase: "J Biol Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.311: 1997;272: 5718-5726.[Abstract/Free FullText] Stewart RJ, Fredenburgh JC, Weitz JI. 

Phrase: "1997"

Phrase: ";272"

Phrase: ":"

Phrase: "5718-5726."

Phrase: "[Abstract/Free FullText"

Phrase: "] Stewart RJ,"

Phrase: "Fredenburgh JC,"

Phrase: "Weitz JI."
Processing 00000000.tx.312: Characterization of the interactions of plasminogen and tissue and vampire bat plasminogen activators with fibrinogen, fibrin, and the complex of D-dimer noncovalently linked to fragment E. 

Phrase: "Characterization of the interactions of plasminogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "vampire bat plasminogen activators with fibrinogen,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0032144:Plasminogen Activators [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   790   C2756980:Plasminogen Activators [Molecular Function]
   753   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C1367553:PLASMINOGEN [Gene or Genome]

Phrase: "fibrin,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   928 E C0443215:Fibrinous [Qualitative Concept]

Phrase: "and"

Phrase: "the complex of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439855:Complex [Qualitative Concept]
   790   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "D-"

Phrase: "dimer noncovalently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596448:dimer [Chemical Viewed Structurally]

Phrase: "linked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "E."
Processing 00000000.tx.313: J Biol Chem. 

Phrase: "J Biol Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.314: 1998;273: 18292-18299.[Abstract/Free FullText] Pike SE, Yao L, Setsuda J, et al. 

Phrase: "1998"

Phrase: ";273"

Phrase: ":"

Phrase: "18292-18299."

Phrase: "[Abstract/Free FullText"

Phrase: "] Pike SE,"

Phrase: "Yao L,"

Phrase: "Setsuda J,"

Phrase: "et al."
Processing 00000000.tx.315: Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth. 

Phrase: "Calreticulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054543:calreticulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413096:CALRETICULIN [Gene or Genome]

Phrase: "and"

Phrase: "calreticulin fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "are"

Phrase: "endothelial cell inhibitors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   983   C1516868:Endothelial Cell Inhibitor [Pharmacologic Substance]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   793 E C1999216:Inhibitor [Qualitative Concept]
   734   C0225336:Endothelial cell [Cell]

Phrase: "that"

Phrase: "suppress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "tumor growth."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0598934:tumor growth [Neoplastic Process]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0027651:Tumor [Neoplastic Process]
   861   C0220844:growth [Physiologic Function]
   861   C1578706:Tumor [Intellectual Product]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   861   C3273930:Tumor [Finding]
Processing 00000000.tx.316: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.317: 1999;94: 2461-2468.[Abstract/Free FullText] Allen S, Bulleid NJ. 

Phrase: "1999"

Phrase: ";94"

Phrase: ":"

Phrase: "2461-2468."

Phrase: "[Abstract/Free FullText"

Phrase: "] Allen S,"

Phrase: "Bulleid NJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]
Processing 00000000.tx.318: Calnexin and calreticulin bind to enzymically active tissue-type plasminogen activator during biosynthesis and are not required for folding to the native conformation. 

Phrase: "Calnexin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0108187:Calnexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413107:CALNEXIN [Gene or Genome]

Phrase: "and"

Phrase: "calreticulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054543:calreticulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413096:CALRETICULIN [Gene or Genome]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "to enzymically active tissue-type plasminogen activator during biosynthesis"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   818   C0032143:Tissue-Type Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
           Tissue Plasminogen Activator
   784   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   764   C0019633:tissue type [Laboratory Procedure]
   764   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   764   C2713035:Tissue type [Tissue]
   742   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0040300:Tissue [Tissue]
   742   C0332307:Type [Qualitative Concept]
   742   C1367553:PLASMINOGEN [Gene or Genome]
   742   C1547052:*Type [Quantitative Concept]
   742   C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "required for folding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0185026:Folding [Therapeutic or Preventive Procedure]
   790   C1514873:Required [Functional Concept]

Phrase: "to the native conformation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026377:Conformation [Spatial Concept]
Processing 00000000.tx.319: Biochem J. 

Phrase: "Biochem J."
Processing 00000000.tx.320: 1997;328: 113-119.[Medline] [OrderarticleviaInfotrieve] Parkkinen J, Rauvala H. 

Phrase: "1997"

Phrase: ";328"

Phrase: ":"

Phrase: "113-119."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Parkkinen J,"

Phrase: "Rauvala H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.321: Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin. 

Phrase: "Interactions of plasminogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "tissue plasminogen activator (t-PA) with amphoterin."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   862   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   806   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0040300:Tissue [Tissue]
   760   C1367553:PLASMINOGEN [Gene or Genome]
   760   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.322: Enhancement of t-PA-catalyzed plasminogen activation by amphoterin. 

Phrase: "Enhancement of t-PA-catalyzed plasminogen activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   744   C2349975:Enhancement [Activity]

Phrase: "by amphoterin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1333908:AMPHOTERIN [Gene or Genome]
Processing 00000000.tx.323: J Biol Chem. 

Phrase: "J Biol Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.324: 1991;266: 16730-16735.[Abstract/Free FullText] Reiher FK, Volpert OV, Jimenez B, et al. 

Phrase: "1991"

Phrase: ";266"

Phrase: ":"

Phrase: "16730-16735."

Phrase: "[Abstract/Free FullText"

Phrase: "] Reiher FK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349396:FK [Geographic Area]
   861   C1150640:FK [Molecular Function]

Phrase: "Volpert OV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0445574:ov [Intellectual Product]

Phrase: "Jimenez B,"

Phrase: "et al."
Processing 00000000.tx.325: Inhibition of tumor growth by systemic treatment with thrombospondin-1 peptide mimetics. 

Phrase: "Inhibition of tumor growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   881   C2249823:inhibition of growth [Organism Function]
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "by systemic treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "with thrombospondin-1 peptide mimetics."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0920591:mimetics [Biomedical Occupation or Discipline]
Processing 00000000.tx.326: Int J Cancer. 

Phrase: "Int J Cancer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006826:Cancer [Neoplastic Process]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]
Processing 00000000.tx.327: 2002;98: 682-689.[CrossRef][Medline] [OrderarticleviaInfotrieve] Paris D, Townsend K, Quadros A, et al. 

Phrase: "2002"

Phrase: ";98"

Phrase: ":"

Phrase: "682-689."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Paris D,"

Phrase: "Townsend K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Quadros A,"

Phrase: "et al."
Processing 00000000.tx.328: Inhibition of angiogenesis by A peptides. 

Phrase: "Inhibition of angiogenesis"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C1510884:inhibition of angiogenesis [Cell Function]
           Angiogenesis Inhibition
   858   C0281318:Angiogenesis Inhibition [Therapeutic or Preventive Procedure]
   858   C2267119:Angiogenesis Inhibition [Molecular Function]
   790   C0021467:Inhibition [Mental Process]
   790   C0021469:Inhibition [Molecular Function]
   790   C1628982:% inhibition [Quantitative Concept]
   790   C3463820:Inhibition [Activity]
   718 E C0311403:Inhibited [Qualitative Concept]

Phrase: "by A peptides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.329: Angiogenesis. 

Phrase: "Angiogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0302600:Angiogenesis [Organ or Tissue Function]
  1000   C1519670:angiogenesis [Neoplastic Process]
Processing 00000000.tx.330: In press.

Phrase: "In press."

